Drugs interactions for

  • 209 Major drug interactions (including ingredients like Abametapir, Abametapir, Abemaciclib)
  • 927 Moderate drug interactions (including ingredients like Abatacept, Abatacept, Abiraterone)
  • 500 Minor drug interactions (including ingredients like Abacavir, Abrocitinib, Aceclofenac)
1636 interactions for
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and .
Abametapir
The serum concentration of Palonosetron can be increased when it is combined with Abametapir.
Abametapir
The serum concentration of Netupitant can be increased when it is combined with Abametapir.
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Netupitant.
Acalabrutinib
The metabolism of Acalabrutinib can be decreased when combined with Netupitant.
Alectinib
The metabolism of Alectinib can be decreased when combined with Netupitant.
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Netupitant.
Amiodarone
The metabolism of Palonosetron can be decreased when combined with Amiodarone.
Amiodarone
The metabolism of Netupitant can be decreased when combined with Amiodarone.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Palonosetron.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Netupitant.
Amoxapine
The metabolism of Amoxapine can be decreased when combined with Palonosetron.
Amoxapine
The metabolism of Amoxapine can be decreased when combined with Netupitant.
Apomorphine
The risk or severity of hypotension can be increased when Palonosetron is combined with Apomorphine.
Atazanavir
The metabolism of Palonosetron can be decreased when combined with Atazanavir.
Atazanavir
The metabolism of Netupitant can be decreased when combined with Atazanavir.
Axitinib
The serum concentration of Axitinib can be increased when it is combined with Netupitant.
Azelastine
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Netupitant.
Bicalutamide
The metabolism of Bicalutamide can be decreased when combined with Netupitant.
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Netupitant.
Bortezomib
The serum concentration of Bortezomib can be increased when it is combined with Netupitant.
Brigatinib
The metabolism of Brigatinib can be decreased when combined with Netupitant.
Bupropion
The metabolism of Palonosetron can be decreased when combined with Bupropion.
Bupropion
The metabolism of Netupitant can be decreased when combined with Bupropion.
Busulfan
The metabolism of Busulfan can be decreased when combined with Netupitant.
Cabazitaxel
The metabolism of Cabazitaxel can be decreased when combined with Netupitant.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Netupitant.
Carbamazepine
The metabolism of Palonosetron can be increased when combined with Carbamazepine.
Carbamazepine
The metabolism of Carbamazepine can be decreased when combined with Netupitant.
Carfilzomib
The serum concentration of Carfilzomib can be increased when it is combined with Netupitant.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Netupitant.
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Netupitant.
Cinacalcet
The metabolism of Palonosetron can be decreased when combined with Cinacalcet.
Cinacalcet
The metabolism of Netupitant can be decreased when combined with Cinacalcet.
Clarithromycin
The metabolism of Palonosetron can be decreased when combined with Clarithromycin.
Clarithromycin
The metabolism of Netupitant can be decreased when combined with Clarithromycin.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Palonosetron.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Netupitant.
Clonidine
The risk or severity of sedation can be increased when Clonidine is combined with Palonosetron.
Clonidine
The metabolism of Clonidine can be decreased when combined with Netupitant.
Conivaptan
The metabolism of Palonosetron can be decreased when combined with Conivaptan.
Conivaptan
The metabolism of Netupitant can be decreased when combined with Conivaptan.
Copanlisib
The metabolism of Copanlisib can be decreased when combined with Netupitant.
Crizotinib
The serum concentration of Crizotinib can be increased when it is combined with Netupitant.
Curcumin
The metabolism of Palonosetron can be decreased when combined with Curcumin.
Curcumin
The metabolism of Netupitant can be decreased when combined with Curcumin.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Netupitant.
Dacomitinib
The metabolism of Dacomitinib can be decreased when combined with Palonosetron.
Dacomitinib
The serum concentration of Dacomitinib can be increased when it is combined with Netupitant.
Dactinomycin
The serum concentration of Dactinomycin can be increased when it is combined with Netupitant.
Danazol
The metabolism of Palonosetron can be decreased when combined with Danazol.
Danazol
The metabolism of Netupitant can be decreased when combined with Danazol.
Darunavir
The metabolism of Palonosetron can be decreased when combined with Darunavir.
Darunavir
The metabolism of Netupitant can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Dasatinib can be increased when it is combined with Netupitant.
Defactinib
The serum concentration of Defactinib can be increased when it is combined with Netupitant.
Dexamethasone
The metabolism of Palonosetron can be increased when combined with Dexamethasone.
Dihydroergotamine
The metabolism of Dihydroergotamine can be decreased when combined with Netupitant.
Docetaxel
The metabolism of Docetaxel can be decreased when combined with Netupitant.
Dofetilide
The metabolism of Dofetilide can be decreased when combined with Netupitant.
Efavirenz
The metabolism of Palonosetron can be decreased when combined with Efavirenz.
Efavirenz
The metabolism of Netupitant can be decreased when combined with Efavirenz.
Elacestrant
The serum concentration of Elacestrant can be increased when it is combined with Netupitant.
Eliglustat
The metabolism of Eliglustat can be decreased when combined with Netupitant.
Elvitegravir
The metabolism of Palonosetron can be decreased when combined with Elvitegravir.
Elvitegravir
The metabolism of Netupitant can be decreased when combined with Elvitegravir.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Palonosetron.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Netupitant.
Entrectinib
The metabolism of Entrectinib can be decreased when combined with Netupitant.
Erdafitinib
The metabolism of Erdafitinib can be decreased when combined with Netupitant.
Ergotamine
The metabolism of Palonosetron can be decreased when combined with Ergotamine.
Ergotamine
The metabolism of Netupitant can be decreased when combined with Ergotamine.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Palonosetron.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Netupitant.
Ethanol
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Etoposide
The serum concentration of Etoposide can be increased when it is combined with Netupitant.
Flecainide
The metabolism of Flecainide can be decreased when combined with Palonosetron.
Flecainide
The metabolism of Flecainide can be decreased when combined with Netupitant.
Flibanserin
The metabolism of Flibanserin can be decreased when combined with Netupitant.
Floxuridine
The metabolism of Netupitant can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Netupitant can be decreased when combined with Fluconazole.
Fosphenytoin
The metabolism of Palonosetron can be increased when combined with Fosphenytoin.
Gemcitabine
The serum concentration of Gemcitabine can be increased when it is combined with Netupitant.
Gemfibrozil
The metabolism of Netupitant can be decreased when combined with Gemfibrozil.
Gilteritinib
The therapeutic efficacy of Palonosetron can be decreased when used in combination with Gilteritinib.
Glycerol phenylbutyrate
The metabolism of Palonosetron can be decreased when combined with Glycerol phenylbutyrate.
Glycerol phenylbutyrate
The metabolism of Netupitant can be decreased when combined with Glycerol phenylbutyrate.
Idelalisib
The metabolism of Idelalisib can be decreased when combined with Netupitant.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Netupitant.
Indinavir
The metabolism of Palonosetron can be decreased when combined with Indinavir.
Indinavir
The metabolism of Netupitant can be decreased when combined with Indinavir.
Infigratinib
The metabolism of Infigratinib can be decreased when combined with Netupitant.
Irinotecan
The metabolism of Irinotecan can be decreased when combined with Netupitant.
Itraconazole
The metabolism of Palonosetron can be decreased when combined with Itraconazole.
Itraconazole
The metabolism of Netupitant can be decreased when combined with Itraconazole.
Ivabradine
The metabolism of Ivabradine can be decreased when combined with Netupitant.
Ixabepilone
The metabolism of Ixabepilone can be decreased when combined with Netupitant.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Netupitant.
Ketoconazole
The metabolism of Palonosetron can be decreased when combined with Ketoconazole.
Ketoconazole
The metabolism of Netupitant can be decreased when combined with Ketoconazole.
Levoketoconazole
The metabolism of Palonosetron can be decreased when combined with Levoketoconazole.
Levoketoconazole
The metabolism of Netupitant can be decreased when combined with Levoketoconazole.
Lomitapide
The metabolism of Lomitapide can be decreased when combined with Netupitant.
Lonafarnib
The metabolism of Palonosetron can be decreased when combined with Lonafarnib.
Lonafarnib
The metabolism of Netupitant can be decreased when combined with Lonafarnib.
Lopinavir
The metabolism of Palonosetron can be decreased when combined with Lopinavir.
Lopinavir
The metabolism of Netupitant can be decreased when combined with Lopinavir.
Lumacaftor
The metabolism of Palonosetron can be increased when combined with Lumacaftor.
Lumacaftor
The metabolism of Netupitant can be increased when combined with Lumacaftor.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Palonosetron.
Methimazole
The metabolism of Palonosetron can be decreased when combined with Methimazole.
Methimazole
The metabolism of Netupitant can be decreased when combined with Methimazole.
Methotrexate
The metabolism of Methotrexate can be decreased when combined with Netupitant.
Methylene blue
Palonosetron may increase the serotonergic activities of Methylene blue.
Miconazole
The metabolism of Netupitant can be decreased when combined with Miconazole.
Midostaurin
The metabolism of Palonosetron can be decreased when combined with Midostaurin.
Midostaurin
The metabolism of Netupitant can be decreased when combined with Midostaurin.
Mitotane
The metabolism of Palonosetron can be increased when combined with Mitotane.
Mitotane
The metabolism of Netupitant can be increased when combined with Mitotane.
Nefazodone
The metabolism of Palonosetron can be decreased when combined with Nefazodone.
Nefazodone
The metabolism of Netupitant can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Palonosetron can be decreased when combined with Nelfinavir.
Nelfinavir
The metabolism of Netupitant can be decreased when combined with Nelfinavir.
Neratinib
The metabolism of Neratinib can be decreased when combined with Netupitant.
Nilotinib
The metabolism of Palonosetron can be decreased when combined with Nilotinib.
Nilotinib
The metabolism of Netupitant can be decreased when combined with Nilotinib.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Palonosetron.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Netupitant.
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Palonosetron is combined with Oliceridine.
Omaveloxolone
The serum concentration of Omaveloxolone can be increased when it is combined with Netupitant.
Orphenadrine
The metabolism of Netupitant can be decreased when combined with Orphenadrine.
Osimertinib
The serum concentration of Osimertinib can be increased when it is combined with Netupitant.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Netupitant.
Pacritinib
The serum concentration of Pacritinib can be increased when it is combined with Netupitant.
Palbociclib
The metabolism of Palbociclib can be decreased when combined with Netupitant.
Paroxetine
The metabolism of Palonosetron can be decreased when combined with Paroxetine.
Paroxetine
The metabolism of Netupitant can be decreased when combined with Paroxetine.
Pentobarbital
The metabolism of Palonosetron can be increased when combined with Pentobarbital.
Pentobarbital
The metabolism of Netupitant can be increased when combined with Pentobarbital.
Pexidartinib
The metabolism of Pexidartinib can be decreased when combined with Netupitant.
Phenobarbital
The metabolism of Palonosetron can be increased when combined with Phenobarbital.
Phenobarbital
The metabolism of Netupitant can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Palonosetron can be increased when combined with Phenytoin.
Pimavanserin
The metabolism of Pimavanserin can be increased when combined with Netupitant.
Pimozide
The metabolism of Pimozide can be decreased when combined with Palonosetron.
Pimozide
The metabolism of Pimozide can be decreased when combined with Netupitant.
Pomalidomide
The serum concentration of Pomalidomide can be increased when it is combined with Netupitant.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Palonosetron.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Netupitant.
Posaconazole
The metabolism of Palonosetron can be decreased when combined with Posaconazole.
Posaconazole
The metabolism of Netupitant can be decreased when combined with Posaconazole.
Pretomanid
The serum concentration of Pretomanid can be increased when it is combined with Netupitant.
Primidone
The metabolism of Palonosetron can be increased when combined with Primidone.
Primidone
The metabolism of Netupitant can be increased when combined with Primidone.
Procainamide
The metabolism of Procainamide can be decreased when combined with Palonosetron.
Procainamide
The metabolism of Procainamide can be decreased when combined with Netupitant.
Propafenone
The metabolism of Palonosetron can be decreased when combined with Propafenone.
Propafenone
The metabolism of Netupitant can be decreased when combined with Propafenone.
Quinidine
The metabolism of Palonosetron can be decreased when combined with Quinidine.
Quinidine
The serum concentration of Quinidine can be increased when it is combined with Netupitant.
Regorafenib
The serum concentration of Regorafenib can be increased when it is combined with Netupitant.
Ribociclib
The metabolism of Palonosetron can be decreased when combined with Ribociclib.
Ribociclib
The metabolism of Netupitant can be decreased when combined with Ribociclib.
Rifampin
The metabolism of Palonosetron can be increased when combined with Rifampicin.
Rifampin
The metabolism of Netupitant can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Palonosetron can be increased when combined with Rifapentine.
Rifapentine
The metabolism of Netupitant can be increased when combined with Rifapentine.
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Netupitant.
Romidepsin
The serum concentration of Romidepsin can be increased when it is combined with Netupitant.
Ruxolitinib
The metabolism of Ruxolitinib can be decreased when combined with Netupitant.
Saquinavir
The metabolism of Palonosetron can be decreased when combined with Saquinavir.
Saquinavir
The metabolism of Netupitant can be decreased when combined with Saquinavir.
Selumetinib
The serum concentration of Selumetinib can be increased when it is combined with Netupitant.
Silodosin
The excretion of Silodosin can be decreased when combined with Netupitant.
Siponimod
The risk or severity of adverse effects can be increased when Netupitant is combined with Siponimod.
Sirolimus
The serum concentration of Sirolimus can be increased when it is combined with Netupitant.
Sodium oxybate
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Sorafenib
The metabolism of Sorafenib can be decreased when combined with Netupitant.
Sotalol
The metabolism of Sotalol can be decreased when combined with Palonosetron.
Sotalol
The metabolism of Sotalol can be decreased when combined with Netupitant.
Sunitinib
The metabolism of Sunitinib can be decreased when combined with Netupitant.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Palonosetron.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Netupitant.
Telithromycin
The metabolism of Palonosetron can be decreased when combined with Telithromycin.
Telithromycin
The metabolism of Netupitant can be decreased when combined with Telithromycin.
Temsirolimus
The serum concentration of Temsirolimus can be increased when it is combined with Netupitant.
Teniposide
The metabolism of Teniposide can be decreased when combined with Netupitant.
Tepotinib
The serum concentration of Tepotinib can be increased when it is combined with Netupitant.
Thalidomide
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Theophylline can be decreased when combined with Palonosetron.
Theophylline
The metabolism of Theophylline can be decreased when combined with Netupitant.
Thioridazine
The metabolism of Palonosetron can be decreased when combined with Thioridazine.
Thioridazine
The metabolism of Netupitant can be decreased when combined with Thioridazine.
Thiotepa
The metabolism of Thiotepa can be decreased when combined with Netupitant.
Tipranavir
The metabolism of Palonosetron can be decreased when combined with Tipranavir.
Tipranavir
The metabolism of Netupitant can be decreased when combined with Tipranavir.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Netupitant.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Palonosetron.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Netupitant.
Trastuzumab emtansine
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Netupitant.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Palonosetron.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Netupitant.
Vandetanib
The metabolism of Vandetanib can be decreased when combined with Netupitant.
Vemurafenib
The serum concentration of Vemurafenib can be increased when it is combined with Netupitant.
Venetoclax
The serum concentration of Venetoclax can be increased when it is combined with Netupitant.
Vinblastine
The serum concentration of Vinblastine can be increased when it is combined with Netupitant.
Vinorelbine
The metabolism of Vinorelbine can be decreased when combined with Netupitant.
Voriconazole
The metabolism of Palonosetron can be decreased when combined with Voriconazole.
Voriconazole
The metabolism of Netupitant can be decreased when combined with Voriconazole.
Abatacept
The metabolism of Palonosetron can be increased when combined with Abatacept.
Abatacept
The metabolism of Netupitant can be increased when combined with Abatacept.
Abiraterone
The metabolism of Palonosetron can be decreased when combined with Abiraterone.
Abiraterone
The metabolism of Netupitant can be decreased when combined with Abiraterone.
Acebutolol
The metabolism of Palonosetron can be decreased when combined with Acebutolol.
Acebutolol
The metabolism of Netupitant can be decreased when combined with Acebutolol.
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Netupitant.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Netupitant.
Acetazolamide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Acetazolamide.
Acetazolamide
The metabolism of Netupitant can be decreased when combined with Acetazolamide.
Acoramidis
The metabolism of Netupitant can be decreased when combined with Acoramidis.
Adagrasib
The metabolism of Palonosetron can be decreased when combined with Adagrasib.
Adagrasib
The metabolism of Adagrasib can be decreased when combined with Netupitant.
Adalimumab
The metabolism of Palonosetron can be increased when combined with Adalimumab.
Adalimumab
The metabolism of Netupitant can be increased when combined with Adalimumab.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Netupitant.
Albendazole
The metabolism of Albendazole can be decreased when combined with Netupitant.
Aldesleukin
The metabolism of Netupitant can be decreased when combined with Aldesleukin.
Alfentanil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Alfentanil.
Alfentanil
The metabolism of Alfentanil can be decreased when combined with Netupitant.
Alfuzosin
The metabolism of Alfuzosin can be decreased when combined with Netupitant.
Aliskiren
The metabolism of Aliskiren can be decreased when combined with Netupitant.
Almotriptan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Almotriptan.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Netupitant.
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Netupitant.
Alosetron
The risk or severity of CNS depression can be increased when Palonosetron is combined with Alosetron.
Alosetron
The metabolism of Alosetron can be decreased when combined with Netupitant.
Alpelisib
The serum concentration of Netupitant can be decreased when it is combined with Alpelisib.
Alprazolam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Alprazolam.
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Netupitant.
Amantadine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Amantadine.
Ambrisentan
The metabolism of Ambrisentan can be decreased when combined with Netupitant.
Amikacin
Palonosetron may decrease the excretion rate of Amikacin which could result in a higher serum level.
Amisulpride
The risk or severity of CNS depression can be increased when Palonosetron is combined with Amisulpride.
Amlodipine
The metabolism of Amlodipine can be decreased when combined with Netupitant.
Amobarbital
The risk or severity of CNS depression can be increased when Palonosetron is combined with Amobarbital.
Amobarbital
The metabolism of Netupitant can be increased when combined with Amobarbital.
Amphetamine
The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Palonosetron.
Anakinra
The metabolism of Palonosetron can be increased when combined with Anakinra.
Anakinra
The metabolism of Netupitant can be increased when combined with Anakinra.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Netupitant.
Apalutamide
The serum concentration of Palonosetron can be decreased when it is combined with Apalutamide.
Apalutamide
The serum concentration of Netupitant can be decreased when it is combined with Apalutamide.
Apixaban
The metabolism of Apixaban can be decreased when combined with Netupitant.
Apremilast
The metabolism of Palonosetron can be increased when combined with Apremilast.
Apremilast
The metabolism of Netupitant can be increased when combined with Apremilast.
Aprepitant
The metabolism of Palonosetron can be decreased when combined with Aprepitant.
Aprepitant
The metabolism of Netupitant can be decreased when combined with Aprepitant.
Aripiprazole
The risk or severity of CNS depression can be increased when Palonosetron is combined with Aripiprazole.
Aripiprazole
The metabolism of Aripiprazole can be decreased when combined with Netupitant.
Aripiprazole lauroxil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Aripiprazole lauroxil.
Aripiprazole lauroxil
The metabolism of Aripiprazole lauroxil can be decreased when combined with Netupitant.
Armodafinil
The metabolism of Netupitant can be increased when combined with Armodafinil.
Artemether
The metabolism of Artemether can be decreased when combined with Netupitant.
Articaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Articaine.
Asciminib
The metabolism of Asciminib can be decreased when combined with Netupitant.
Asenapine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Asenapine.
Asenapine
The metabolism of Asenapine can be decreased when combined with Netupitant.
Asunaprevir
The metabolism of Palonosetron can be decreased when combined with Asunaprevir.
Asunaprevir
The metabolism of Netupitant can be decreased when combined with Asunaprevir.
Atogepant
The metabolism of Atogepant can be decreased when combined with Netupitant.
Atorvastatin
The metabolism of Atorvastatin can be decreased when combined with Netupitant.
Atovaquone
The metabolism of Atovaquone can be decreased when combined with Netupitant.
Atracurium besylate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Atracurium besylate.
Avacopan
The metabolism of Avacopan can be decreased when combined with Netupitant.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Palonosetron.
Avanafil
The metabolism of Avanafil can be decreased when combined with Netupitant.
Avapritinib
The metabolism of Avapritinib can be decreased when combined with Netupitant.
Avatrombopag
The metabolism of Avatrombopag can be decreased when combined with Netupitant.
Avutometinib
The metabolism of Avutometinib can be decreased when combined with Netupitant.
Azelastine
The metabolism of Azelastine can be decreased when combined with Netupitant.
Azithromycin
The metabolism of Azithromycin can be decreased when combined with Netupitant.
Baricitinib
The metabolism of Baricitinib can be decreased when combined with Netupitant.
Beclomethasone dipropionate
The metabolism of Beclomethasone dipropionate can be decreased when combined with Netupitant.
Bedaquiline
The metabolism of Bedaquiline can be decreased when combined with Netupitant.
Belinostat
The serum concentration of Belinostat can be increased when it is combined with Netupitant.
Belumosudil
The metabolism of Belumosudil can be decreased when combined with Netupitant.
Benzocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Benzocaine.
Benzphetamine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Benzphetamine.
Benzphetamine
The metabolism of Benzphetamine can be decreased when combined with Netupitant.
Benzyl alcohol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Benzyl alcohol.
Berotralstat
The metabolism of Palonosetron can be decreased when combined with Berotralstat.
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Netupitant.
Betamethasone
The metabolism of Betamethasone can be decreased when combined with Netupitant.
Betrixaban
The serum concentration of Betrixaban can be increased when it is combined with Netupitant.
Bexarotene
The metabolism of Netupitant can be increased when combined with Bexarotene.
Bictegravir
The metabolism of Bictegravir can be decreased when combined with Netupitant.
Bimekizumab
The metabolism of Palonosetron can be increased when combined with Bimekizumab.
Bimekizumab
The metabolism of Netupitant can be increased when combined with Bimekizumab.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Netupitant.
Bosentan
The metabolism of Netupitant can be increased when combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Netupitant.
Botulinum toxin type B
The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Palonosetron.
Brentuximab vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Netupitant.
Brexanolone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Brexanolone.
Brexpiprazole
The risk or severity of CNS depression can be increased when Palonosetron is combined with Brexpiprazole.
Brexpiprazole
The metabolism of Brexpiprazole can be decreased when combined with Netupitant.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Brivaracetam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Brivaracetam.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Netupitant.
Bromocriptine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Bromocriptine.
Bromocriptine
The metabolism of Bromocriptine can be decreased when combined with Netupitant.
Brompheniramine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Brompheniramine.
Budesonide
The metabolism of Budesonide can be decreased when combined with Netupitant.
Bupivacaine
The risk or severity of CNS depression can be increased when Bupivacaine is combined with Palonosetron.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Netupitant.
Buprenorphine
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Netupitant.
Buspirone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Buspirone.
Buspirone
The metabolism of Buspirone can be decreased when combined with Netupitant.
Butalbital
The risk or severity of CNS depression can be increased when Butalbital is combined with Palonosetron.
Butalbital
The metabolism of Netupitant can be increased when combined with Butalbital.
Butorphanol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Butorphanol.
Cabergoline
The risk or severity of CNS depression can be increased when Cabergoline is combined with Palonosetron.
Cabozantinib
The metabolism of Cabozantinib can be decreased when combined with Netupitant.
Calcitriol
The metabolism of Calcitriol can be decreased when combined with Netupitant.
Canagliflozin
The metabolism of Canagliflozin can be decreased when combined with Netupitant.
Canakinumab
The metabolism of Palonosetron can be increased when combined with Canakinumab.
Canakinumab
The metabolism of Netupitant can be increased when combined with Canakinumab.
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Palonosetron.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Netupitant.
Capecitabine
The serum concentration of Netupitant can be increased when it is combined with Capecitabine.
Capivasertib
The serum concentration of Capivasertib can be increased when it is combined with Netupitant.
Capmatinib
The metabolism of Capmatinib can be decreased when combined with Netupitant.
Capreomycin
Palonosetron may decrease the excretion rate of Capreomycin which could result in a higher serum level.
Capsaicin
The metabolism of Netupitant can be decreased when combined with Capsaicin.
Carbinoxamine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Carbinoxamine.
Cariprazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Palonosetron.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Netupitant.
Celecoxib
The metabolism of Palonosetron can be decreased when combined with Celecoxib.
Celecoxib
The metabolism of Netupitant can be decreased when combined with Celecoxib.
Cenobamate
The serum concentration of Palonosetron can be decreased when it is combined with Cenobamate.
Cenobamate
The serum concentration of Netupitant can be decreased when it is combined with Cenobamate.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Netupitant.
Certolizumab pegol
The metabolism of Palonosetron can be increased when combined with Certolizumab pegol.
Certolizumab pegol
The metabolism of Netupitant can be increased when combined with Certolizumab pegol.
Cetirizine
The risk or severity of CNS depression can be increased when Cetirizine is combined with Palonosetron.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Netupitant.
Chenodeoxycholic acid
The metabolism of Chenodeoxycholic acid can be decreased when combined with Netupitant.
Chloramphenicol
The metabolism of Netupitant can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Chlordiazepoxide.
Chloroprocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Chloroprocaine.
Chloroquine
The metabolism of Palonosetron can be decreased when combined with Chloroquine.
Chloroquine
The metabolism of Netupitant can be decreased when combined with Chloroquine.
Chlorpheniramine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Chlorpheniramine.
Chlorpheniramine
The metabolism of Chlorpheniramine can be decreased when combined with Netupitant.
Chlorpromazine
The metabolism of Palonosetron can be decreased when combined with Chlorpromazine.
Chlorpromazine
The metabolism of Netupitant can be decreased when combined with Chlorpromazine.
Chlorzoxazone
The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Palonosetron.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Netupitant.
Cholecalciferol
The metabolism of Palonosetron can be decreased when combined with Cholecalciferol.
Cholecalciferol
The metabolism of Netupitant can be decreased when combined with Cholecalciferol.
Ciclesonide
The metabolism of Ciclesonide can be decreased when combined with Netupitant.
Cilostazol
The metabolism of Cilostazol can be decreased when combined with Netupitant.
Cimetidine
The metabolism of Netupitant can be decreased when combined with Cimetidine.
Cinchocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Cinchocaine.
Ciprofloxacin
The metabolism of Palonosetron can be decreased when combined with Ciprofloxacin.
Ciprofloxacin
The metabolism of Netupitant can be decreased when combined with Ciprofloxacin.
Cisatracurium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Cisatracurium.
Cisplatin
Palonosetron may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Citalopram
The risk or severity of adverse effects can be increased when Palonosetron is combined with Citalopram.
Citalopram
The metabolism of Citalopram can be decreased when combined with Netupitant.
Clemastine
The risk or severity of CNS depression can be increased when Clemastine is combined with Palonosetron.
Clemastine
The metabolism of Netupitant can be decreased when combined with Clemastine.
Clevidipine
The metabolism of Clevidipine can be decreased when combined with Netupitant.
Clidinium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Clidinium.
Clindamycin
The metabolism of Clindamycin can be decreased when combined with Netupitant.
Clobazam
The serum concentration of Palonosetron can be increased when it is combined with Clobazam.
Clobazam
The serum concentration of Netupitant can be increased when it is combined with Clobazam.
Clobetasol propionate
The metabolism of Clobetasol propionate can be decreased when combined with Netupitant.
Clomifene
The serum concentration of Clomifene can be increased when it is combined with Netupitant.
Clonazepam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Clonazepam.
Clonazepam
The metabolism of Clonazepam can be decreased when combined with Netupitant.
Clopidogrel
The metabolism of Clopidogrel can be decreased when combined with Netupitant.
Clorazepic acid
The risk or severity of CNS depression can be increased when Palonosetron is combined with Clorazepic acid.
Clorazepic acid
The metabolism of Clorazepic acid can be decreased when combined with Netupitant.
Clozapine
The serum concentration of Palonosetron can be increased when it is combined with Clozapine.
Clozapine
The serum concentration of Clozapine can be increased when it is combined with Netupitant.
Cobicistat
The metabolism of Cobicistat can be decreased when combined with Netupitant.
Cobimetinib
The metabolism of Cobimetinib can be decreased when combined with Netupitant.
Cocaine
The metabolism of Palonosetron can be decreased when combined with Cocaine.
Cocaine
The metabolism of Netupitant can be decreased when combined with Cocaine.
Codeine
The risk or severity of CNS depression can be increased when Codeine is combined with Palonosetron.
Codeine
The metabolism of Codeine can be decreased when combined with Netupitant.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Netupitant.
Colistin
Palonosetron may decrease the excretion rate of Colistin which could result in a higher serum level.
Conjugated estrogens
The metabolism of Conjugated estrogens can be decreased when combined with Netupitant.
Corticotropin
The metabolism of Corticotropin can be decreased when combined with Netupitant.
Cortisone acetate
The metabolism of Cortisone acetate can be decreased when combined with Netupitant.
Crinecerfont
The metabolism of Crinecerfont can be decreased when combined with Netupitant.
Cyclobenzaprine
The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Palonosetron.
Cyclobenzaprine
The metabolism of Cyclobenzaprine can be decreased when combined with Netupitant.
Cyclosporine
The metabolism of Palonosetron can be decreased when combined with Cyclosporine.
Cyclosporine
The metabolism of Netupitant can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Cyproheptadine.
Dabigatran etexilate
The serum concentration of Dabigatran etexilate can be increased when it is combined with Netupitant.
Dabrafenib
The serum concentration of Palonosetron can be decreased when it is combined with Dabrafenib.
Dabrafenib
The serum concentration of Netupitant can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dantrolene.
Dapsone
The metabolism of Dapsone can be decreased when combined with Netupitant.
Daptomycin
The serum concentration of Daptomycin can be increased when it is combined with Netupitant.
Daridorexant
The metabolism of Daridorexant can be decreased when combined with Netupitant.
Darifenacin
The metabolism of Palonosetron can be decreased when combined with Darifenacin.
Darifenacin
The metabolism of Netupitant can be decreased when combined with Darifenacin.
Darolutamide
The metabolism of Darolutamide can be decreased when combined with Netupitant.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Netupitant.
Daunorubicin
The metabolism of Netupitant can be decreased when combined with Daunorubicin.
Deferasirox
The metabolism of Netupitant can be increased when combined with Deferasirox.
Deflazacort
The serum concentration of Deflazacort can be increased when it is combined with Netupitant.
Desflurane
The risk or severity of CNS depression can be increased when Palonosetron is combined with Desflurane.
Desipramine
The metabolism of Palonosetron can be decreased when combined with Desipramine.
Desipramine
The metabolism of Netupitant can be decreased when combined with Desipramine.
Desloratadine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Desloratadine.
Desogestrel
The metabolism of Desogestrel can be decreased when combined with Netupitant.
Desvenlafaxine
The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Palonosetron.
Deuruxolitinib
The metabolism of Deuruxolitinib can be decreased when combined with Netupitant.
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Netupitant.
Deutivacaftor
The serum concentration of Netupitant can be increased when it is combined with Deutivacaftor.
Dexamethasone acetate
The metabolism of Netupitant can be increased when combined with Dexamethasone acetate.
Dexbrompheniramine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dexbrompheniramine.
Dexchlorpheniramine maleate
The metabolism of Palonosetron can be decreased when combined with Dexchlorpheniramine maleate.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Netupitant.
Dexlansoprazole
The metabolism of Dexlansoprazole can be decreased when combined with Netupitant.
Dexmedetomidine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dexmedetomidine.
Dexmedetomidine
The metabolism of Netupitant can be decreased when combined with Dexmedetomidine.
Dexmethylphenidate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dexmethylphenidate.
Dextroamphetamine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Dextroamphetamine.
Dextromethorphan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dextromethorphan.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Netupitant.
Dextropropoxyphene
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dextropropoxyphene.
Dextropropoxyphene
The metabolism of Dextropropoxyphene can be decreased when combined with Netupitant.
Diazepam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Diazepam.
Diazepam
The metabolism of Diazepam can be decreased when combined with Netupitant.
Diazoxide
The metabolism of Diazoxide can be decreased when combined with Netupitant.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Netupitant.
Dicloxacillin
The metabolism of Netupitant can be increased when combined with Dicloxacillin.
Dienogest
The metabolism of Dienogest can be decreased when combined with Netupitant.
Diethylpropion
The risk or severity of CNS depression can be increased when Palonosetron is combined with Diethylpropion.
Difenoxin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Difenoxin.
Digoxin
Palonosetron may decrease the excretion rate of Digoxin which could result in a higher serum level.
Digoxin
Netupitant may decrease the excretion rate of Digoxin which could result in a higher serum level.
Dihydro-alpha-ergocryptine
The metabolism of Dihydro-alpha-ergocryptine can be decreased when combined with Netupitant.
Dihydrocodeine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dihydrocodeine.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Netupitant.
Dihydroergocornine
The metabolism of Dihydroergocornine can be decreased when combined with Netupitant.
Dihydroergocristine
The metabolism of Dihydroergocristine can be decreased when combined with Netupitant.
Dihydroergotamine
The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Palonosetron.
Diltiazem
The metabolism of Palonosetron can be decreased when combined with Diltiazem.
Diltiazem
The metabolism of Netupitant can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dimenhydrinate.
Dimethyl sulfoxide
The metabolism of Palonosetron can be decreased when combined with Dimethyl sulfoxide.
Dimethyl sulfoxide
The metabolism of Netupitant can be decreased when combined with Dimethyl sulfoxide.
Diosmin
The metabolism of Netupitant can be decreased when combined with Diosmin.
Diphenhydramine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Diphenhydramine.
Diphenhydramine
The metabolism of Netupitant can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Diphenoxylate.
Disopyramide
The metabolism of Disopyramide can be decreased when combined with Netupitant.
Disulfiram
The metabolism of Disulfiram can be decreased when combined with Netupitant.
Doconexent
The metabolism of Netupitant can be decreased when combined with Doconexent.
Dolasetron
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dolasetron.
Dolasetron
The metabolism of Dolasetron can be decreased when combined with Netupitant.
Dolutegravir
The serum concentration of Dolutegravir can be increased when it is combined with Netupitant.
Donepezil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Donepezil.
Donepezil
The metabolism of Donepezil can be decreased when combined with Netupitant.
Doravirine
The metabolism of Doravirine can be decreased when combined with Netupitant.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Netupitant.
Doxepin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Doxepin.
Doxepin
The metabolism of Doxepin can be decreased when combined with Netupitant.
Doxorubicin
The metabolism of Palonosetron can be decreased when combined with Doxorubicin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Netupitant.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Dronabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Dronabinol
The serum concentration of Dronabinol can be increased when it is combined with Netupitant.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Drospirenone
The metabolism of Drospirenone can be decreased when combined with Netupitant.
Duloxetine
The metabolism of Palonosetron can be decreased when combined with Duloxetine.
Duloxetine
The metabolism of Netupitant can be decreased when combined with Duloxetine.
Duvelisib
The metabolism of Duvelisib can be decreased when combined with Netupitant.
Dyclonine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Dyclonine.
Echinacea
The metabolism of Netupitant can be increased when combined with Echinacea.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Netupitant.
Elafibranor
The metabolism of Netupitant can be increased when combined with Elafibranor.
Elagolix
The serum concentration of Elagolix can be increased when it is combined with Netupitant.
Elbasvir
The metabolism of Elbasvir can be decreased when combined with Netupitant.
Eletriptan
The risk or severity of CNS depression can be increased when Eletriptan is combined with Palonosetron.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Netupitant.
Elexacaftor
The serum concentration of Elexacaftor can be increased when it is combined with Netupitant.
Eliglustat
The metabolism of Palonosetron can be decreased when combined with Eliglustat.
Eluxadoline
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Eluxadoline.
Emapalumab
The metabolism of Palonosetron can be increased when combined with Emapalumab.
Emapalumab
The metabolism of Netupitant can be increased when combined with Emapalumab.
Encorafenib
The metabolism of Palonosetron can be decreased when combined with Encorafenib.
Encorafenib
The serum concentration of Encorafenib can be increased when it is combined with Netupitant.
Enfortumab vedotin
The metabolism of Enfortumab vedotin can be decreased when combined with Netupitant.
Entacapone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Entacapone.
Enzalutamide
The serum concentration of Palonosetron can be decreased when it is combined with Enzalutamide.
Enzalutamide
The serum concentration of Netupitant can be decreased when it is combined with Enzalutamide.
Epcoritamab
The serum concentration of Palonosetron can be increased when it is combined with Epcoritamab.
Epcoritamab
The serum concentration of Netupitant can be increased when it is combined with Epcoritamab.
Epinastine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Epinastine.
Epinastine
The metabolism of Epinastine can be decreased when combined with Netupitant.
Epinephrine
The metabolism of Netupitant can be decreased when combined with Epinephrine.
Eplerenone
The metabolism of Eplerenone can be decreased when combined with Netupitant.
Eravacycline
The metabolism of Eravacycline can be decreased when combined with Netupitant.
Erythromycin
The serum concentration of Palonosetron can be increased when it is combined with Erythromycin.
Erythromycin
The serum concentration of Netupitant can be increased when it is combined with Erythromycin.
Escitalopram
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Escitalopram.
Escitalopram
The serum concentration of Netupitant can be increased when it is combined with Escitalopram.
Esketamine
The risk or severity of adverse effects can be increased when Palonosetron is combined with Esketamine.
Esketamine
The metabolism of Esketamine can be decreased when combined with Netupitant.
Eslicarbazepine acetate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Eslicarbazepine acetate.
Eslicarbazepine acetate
The metabolism of Netupitant can be increased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Esomeprazole can be decreased when combined with Netupitant.
Estazolam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Estazolam.
Estazolam
The metabolism of Estazolam can be decreased when combined with Netupitant.
Esterified estrogens
The metabolism of Esterified estrogens can be decreased when combined with Netupitant.
Estetrol
The metabolism of Estetrol can be decreased when combined with Netupitant.
Estradiol
The metabolism of Estradiol can be decreased when combined with Netupitant.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Netupitant.
Estradiol cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Netupitant.
Estradiol valerate
The metabolism of Estradiol valerate can be decreased when combined with Netupitant.
Estrone sulfate
The metabolism of Estrone sulfate can be decreased when combined with Netupitant.
Eszopiclone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Eszopiclone.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Netupitant.
Etanercept
The metabolism of Palonosetron can be increased when combined with Etanercept.
Etanercept
The metabolism of Netupitant can be increased when combined with Etanercept.
Ethanol
The metabolism of Ethanol can be decreased when combined with Netupitant.
Ethinylestradiol
The metabolism of Ethinylestradiol can be decreased when combined with Netupitant.
Ethosuximide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ethosuximide.
Ethosuximide
The metabolism of Ethosuximide can be decreased when combined with Netupitant.
Ethotoin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ethotoin.
Ethynodiol diacetate
The metabolism of Ethynodiol diacetate can be decreased when combined with Netupitant.
Etomidate
The risk or severity of CNS depression can be increased when Etomidate is combined with Palonosetron.
Etonogestrel
The metabolism of Etonogestrel can be decreased when combined with Netupitant.
Etrasimod
The serum concentration of Etrasimod can be increased when it is combined with Netupitant.
Etravirine
The metabolism of Netupitant can be increased when combined with Etravirine.
Everolimus
The metabolism of Palonosetron can be decreased when combined with Everolimus.
Everolimus
The metabolism of Everolimus can be decreased when combined with Netupitant.
Exemestane
The metabolism of Exemestane can be decreased when combined with Netupitant.
Fedratinib
The serum concentration of Palonosetron can be increased when it is combined with Fedratinib.
Fedratinib
The serum concentration of Netupitant can be increased when it is combined with Fedratinib.
Felbamate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Felbamate.
Felbamate
The metabolism of Felbamate can be decreased when combined with Netupitant.
Felodipine
The metabolism of Palonosetron can be decreased when combined with Felodipine.
Felodipine
The metabolism of Felodipine can be decreased when combined with Netupitant.
Fenfluramine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Fenfluramine.
Fenfluramine
The metabolism of Netupitant can be decreased when combined with Fenfluramine.
Fenofibrate
The metabolism of Fenofibrate can be decreased when combined with Netupitant.
Fentanyl
The risk or severity of CNS depression can be increased when Palonosetron is combined with Fentanyl.
Fentanyl
The metabolism of Fentanyl can be decreased when combined with Netupitant.
Fesoterodine
The metabolism of Fesoterodine can be decreased when combined with Netupitant.
Fexinidazole
The metabolism of Fexinidazole can be decreased when combined with Netupitant.
Fexofenadine
The serum concentration of Fexofenadine can be increased when it is combined with Netupitant.
Finasteride
The metabolism of Finasteride can be decreased when combined with Netupitant.
Finerenone
The serum concentration of Finerenone can be increased when it is combined with Netupitant.
Fish oil
The metabolism of Fish oil can be decreased when combined with Netupitant.
Flibanserin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Flibanserin.
Fluconazole
The metabolism of Palonosetron can be decreased when combined with Fluconazole.
Fludrocortisone
The metabolism of Fludrocortisone can be decreased when combined with Netupitant.
Flunisolide
The metabolism of Netupitant can be increased when combined with Flunisolide.
Fluocinolone acetonide
The metabolism of Fluocinolone acetonide can be decreased when combined with Netupitant.
Fluocinonide
The metabolism of Fluocinonide can be decreased when combined with Netupitant.
Fluorouracil
The metabolism of Netupitant can be decreased when combined with Fluorouracil.
Fluoxetine
The serum concentration of Palonosetron can be increased when it is combined with Fluoxetine.
Fluoxetine
The serum concentration of Netupitant can be increased when it is combined with Fluoxetine.
Fluphenazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Fluphenazine.
Flurazepam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Flurazepam.
Flurazepam
The metabolism of Flurazepam can be decreased when combined with Netupitant.
Flutamide
The metabolism of Flutamide can be decreased when combined with Netupitant.
Fluticasone furoate
The serum concentration of Fluticasone furoate can be increased when it is combined with Netupitant.
Fluticasone propionate
The risk or severity of CNS depression can be increased when Palonosetron is combined with Fluticasone propionate.
Fluticasone propionate
The metabolism of Fluticasone propionate can be decreased when combined with Netupitant.
Fluvastatin
The metabolism of Fluvastatin can be decreased when combined with Netupitant.
Fluvoxamine
The metabolism of Palonosetron can be decreased when combined with Fluvoxamine.
Fluvoxamine
The metabolism of Netupitant can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Fosamprenavir can be decreased when combined with Netupitant.
Fosaprepitant
The metabolism of Fosaprepitant can be decreased when combined with Netupitant.
Fosnetupitant
The metabolism of Fosnetupitant can be decreased when combined with Netupitant.
Fosphenytoin
The metabolism of Netupitant can be increased when combined with Fosphenytoin.
Fostamatinib
The metabolism of Fostamatinib can be decreased when combined with Netupitant.
Fostemsavir
The metabolism of Fostemsavir can be decreased when combined with Netupitant.
Frovatriptan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Frovatriptan.
Fruquintinib
The metabolism of Fruquintinib can be decreased when combined with Netupitant.
Fusidic acid
The metabolism of Palonosetron can be decreased when combined with Fusidic acid.
Fusidic acid
The metabolism of Netupitant can be decreased when combined with Fusidic acid.
Futibatinib
The serum concentration of Futibatinib can be increased when it is combined with Netupitant.
Gabapentin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Gabapentin.
Gabapentin enacarbil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Gabapentin enacarbil.
Galantamine
The metabolism of Galantamine can be decreased when combined with Netupitant.
gamma-Hydroxybutyric acid
The risk or severity of CNS depression can be increased when Palonosetron is combined with gamma-Hydroxybutyric acid.
Ganaxolone
The risk or severity of sedation, somnolence, and CNS depression can be increased when Palonosetron is combined with Ganaxolone.
Gefitinib
The metabolism of Gefitinib can be decreased when combined with Netupitant.
Genistein
The metabolism of Netupitant can be increased when combined with Genistein.
Gentamicin
Palonosetron may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Gepirone
The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Palonosetron.
Gepirone
The serum concentration of Gepirone can be increased when it is combined with Netupitant.
Gepotidacin
The metabolism of Gepotidacin can be decreased when combined with Netupitant.
Gestodene
The metabolism of Gestodene can be decreased when combined with Netupitant.
Gilteritinib
The metabolism of Gilteritinib can be decreased when combined with Netupitant.
Ginkgo biloba
The metabolism of Netupitant can be decreased when combined with Ginkgo biloba.
Givosiran
The serum concentration of Palonosetron can be increased when it is combined with Givosiran.
Givosiran
The serum concentration of Netupitant can be increased when it is combined with Givosiran.
Glasdegib
The metabolism of Glasdegib can be decreased when combined with Netupitant.
Glecaprevir
The serum concentration of Glecaprevir can be increased when it is combined with Netupitant.
Glofitamab
The serum concentration of Palonosetron can be increased when it is combined with Glofitamab.
Glofitamab
The serum concentration of Netupitant can be increased when it is combined with Glofitamab.
Glyburide
The metabolism of Glyburide can be decreased when combined with Netupitant.
Golimumab
The metabolism of Palonosetron can be increased when combined with Golimumab.
Golimumab
The metabolism of Netupitant can be increased when combined with Golimumab.
Granisetron
The risk or severity of CNS depression can be increased when Palonosetron is combined with Granisetron.
Granisetron
The metabolism of Granisetron can be decreased when combined with Netupitant.
Grapefruit
The metabolism of Netupitant can be decreased when combined with Grapefruit.
Grazoprevir
The metabolism of Grazoprevir can be decreased when combined with Netupitant.
Griseofulvin
The metabolism of Netupitant can be increased when combined with Griseofulvin.
Guanfacine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Guanfacine.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Netupitant.
Haloperidol
The risk or severity of CNS depression can be increased when Haloperidol is combined with Palonosetron.
Haloperidol
The serum concentration of Haloperidol can be increased when it is combined with Netupitant.
Hydralazine
The metabolism of Netupitant can be decreased when combined with Hydralazine.
Hydrocodone
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydrocodone
The metabolism of Hydrocodone can be decreased when combined with Netupitant.
Hydrocortisone
The metabolism of Hydrocortisone can be decreased when combined with Netupitant.
Hydrocortisone acetate
The metabolism of Hydrocortisone acetate can be decreased when combined with Netupitant.
Hydrocortisone butyrate
The metabolism of Hydrocortisone butyrate can be decreased when combined with Netupitant.
Hydrocortisone succinate
The metabolism of Hydrocortisone succinate can be decreased when combined with Netupitant.
Hydromorphone
The risk or severity of CNS depression can be increased when Hydromorphone is combined with Palonosetron.
Hydroxychloroquine
The metabolism of Palonosetron can be decreased when combined with Hydroxychloroquine.
Hydroxychloroquine
The metabolism of Hydroxychloroquine can be decreased when combined with Netupitant.
Hydroxyprogesterone caproate
The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Netupitant.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Hydroxyzine
The metabolism of Hydroxyzine can be decreased when combined with Netupitant.
Ibrexafungerp
The metabolism of Ibrexafungerp can be decreased when combined with Netupitant.
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Netupitant.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Netupitant.
Iloperidone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Iloperidone.
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Netupitant.
Imipramine
The metabolism of Palonosetron can be decreased when combined with Imipramine.
Imipramine
The metabolism of Netupitant can be decreased when combined with Imipramine.
Indapamide
The metabolism of Indapamide can be decreased when combined with Netupitant.
Infliximab
The metabolism of Palonosetron can be increased when combined with Infliximab.
Infliximab
The metabolism of Netupitant can be increased when combined with Infliximab.
Ipecac
The metabolism of Ipecac can be decreased when combined with Netupitant.
Irbesartan
The metabolism of Netupitant can be decreased when combined with Irbesartan.
Isavuconazonium
The metabolism of Palonosetron can be decreased when combined with Isavuconazonium.
Isavuconazonium
The metabolism of Netupitant can be decreased when combined with Isavuconazonium.
Isocarboxazid
The risk or severity of CNS depression can be increased when Palonosetron is combined with Isocarboxazid.
Isoflurane
The risk or severity of CNS depression can be increased when Palonosetron is combined with Isoflurane.
Isoniazid
The metabolism of Palonosetron can be decreased when combined with Isoniazid.
Isoniazid
The metabolism of Netupitant can be decreased when combined with Isoniazid.
Isotretinoin
The metabolism of Isotretinoin can be decreased when combined with Netupitant.
Isradipine
The metabolism of Palonosetron can be decreased when combined with Isradipine.
Isradipine
The metabolism of Netupitant can be decreased when combined with Isradipine.
Istradefylline
The metabolism of Istradefylline can be decreased when combined with Netupitant.
Ivacaftor
The serum concentration of Palonosetron can be increased when it is combined with Ivacaftor.
Ivacaftor
The metabolism of Ivacaftor can be decreased when combined with Netupitant.
Ivermectin
The metabolism of Ivermectin can be decreased when combined with Netupitant.
Ivosidenib
The metabolism of Palonosetron can be increased when combined with Ivosidenib.
Ivosidenib
The metabolism of Ivosidenib can be decreased when combined with Netupitant.
Ketamine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ketamine.
Ketamine
The metabolism of Ketamine can be decreased when combined with Netupitant.
Labetalol
The metabolism of Palonosetron can be decreased when combined with Labetalol.
Labetalol
The metabolism of Netupitant can be decreased when combined with Labetalol.
Lacosamide
The metabolism of Lacosamide can be decreased when combined with Netupitant.
Lamotrigine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Lamotrigine.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Netupitant.
Lapatinib
The metabolism of Lapatinib can be decreased when combined with Netupitant.
Larotrectinib
The metabolism of Larotrectinib can be decreased when combined with Netupitant.
Lasmiditan
The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Palonosetron.
Lasmiditan
The serum concentration of Lasmiditan can be increased when it is combined with Netupitant.
Lazertinib
The metabolism of Lazertinib can be decreased when combined with Netupitant.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Netupitant.
Lefamulin
Netupitant may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Leflunomide
The metabolism of Netupitant can be decreased when combined with Leflunomide.
Lemborexant
The risk or severity of CNS depression can be increased when Palonosetron is combined with Lemborexant.
Lemborexant
The metabolism of Lemborexant can be decreased when combined with Netupitant.
Lenacapavir
The metabolism of Lenacapavir can be decreased when combined with Netupitant.
Lenvatinib
The serum concentration of Lenvatinib can be increased when it is combined with Netupitant.
Letermovir
The metabolism of Netupitant can be decreased when combined with Letermovir.
Letrozole
The metabolism of Letrozole can be decreased when combined with Netupitant.
Levamlodipine
The serum concentration of Levamlodipine can be increased when it is combined with Netupitant.
Levetiracetam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Levetiracetam.
Levocetirizine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Levocetirizine.
Levocetirizine
The metabolism of Levocetirizine can be decreased when combined with Netupitant.
Levodopa
The risk or severity of CNS depression can be increased when Palonosetron is combined with Levodopa.
Levomenthol
The metabolism of Levomenthol can be decreased when combined with Netupitant.
Levomilnacipran
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Levomilnacipran.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Netupitant.
Levonorgestrel
The metabolism of Levonorgestrel can be decreased when combined with Netupitant.
Levorphanol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Levorphanol.
Lidocaine
The risk or severity of CNS depression can be increased when Lidocaine is combined with Palonosetron.
Lidocaine
The metabolism of Lidocaine can be decreased when combined with Netupitant.
Linagliptin
The metabolism of Palonosetron can be decreased when combined with Linagliptin.
Linagliptin
The metabolism of Netupitant can be decreased when combined with Linagliptin.
Linezolid
The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Palonosetron.
Lisdexamfetamine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Lisdexamfetamine.
Lithium carbonate
Palonosetron may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Lofexidine
The therapeutic efficacy of Palonosetron can be increased when used in combination with Lofexidine.
Loncastuximab tesirine
The serum concentration of Loncastuximab tesirine can be increased when it is combined with Netupitant.
Loratadine
The metabolism of Loratadine can be decreased when combined with Netupitant.
Lorazepam
The risk or severity of CNS depression can be increased when Lorazepam is combined with Palonosetron.
Lorlatinib
The metabolism of Lorlatinib can be decreased when combined with Netupitant.
Losartan
The metabolism of Losartan can be decreased when combined with Netupitant.
Lovastatin
The metabolism of Lovastatin can be decreased when combined with Netupitant.
Loxapine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Loxapine.
Lumateperone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Lumateperone.
Lumateperone
The serum concentration of Lumateperone can be increased when it is combined with Netupitant.
Lumefantrine
The metabolism of Palonosetron can be decreased when combined with Lumefantrine.
Lumefantrine
The metabolism of Netupitant can be decreased when combined with Lumefantrine.
Lurasidone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Lurasidone.
Lurasidone
The metabolism of Lurasidone can be decreased when combined with Netupitant.
Lurbinectedin
The serum concentration of Lurbinectedin can be increased when it is combined with Netupitant.
Lusutrombopag
The serum concentration of Lusutrombopag can be increased when it is combined with Netupitant.
Macimorelin
The metabolism of Macimorelin can be decreased when combined with Netupitant.
Macitentan
The metabolism of Macitentan can be decreased when combined with Netupitant.
Magnesium sulfate
The therapeutic efficacy of Palonosetron can be increased when used in combination with Magnesium sulfate.
Mannitol
The serum concentration of Mannitol can be increased when it is combined with Netupitant.
Maprotiline
The risk or severity of CNS depression can be increased when Palonosetron is combined with Maprotiline.
Maraviroc
The metabolism of Maraviroc can be decreased when combined with Netupitant.
Maribavir
The metabolism of Maribavir can be decreased when combined with Netupitant.
Mavacamten
The serum concentration of Palonosetron can be decreased when it is combined with Mavacamten.
Mavacamten
The serum concentration of Mavacamten can be increased when it is combined with Netupitant.
Mavorixafor
The metabolism of Palonosetron can be decreased when combined with Mavorixafor.
Mavorixafor
The metabolism of Mavorixafor can be decreased when combined with Netupitant.
Meclizine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Meclizine.
Medroxyprogesterone acetate
The metabolism of Medroxyprogesterone acetate can be decreased when combined with Netupitant.
Mefloquine
The metabolism of Mefloquine can be decreased when combined with Netupitant.
Megestrol acetate
The metabolism of Megestrol acetate can be decreased when combined with Netupitant.
Melatonin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Melatonin.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Netupitant.
Meperidine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Meperidine.
Meperidine
The metabolism of Meperidine can be decreased when combined with Netupitant.
Mepivacaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Mepivacaine.
Meprobamate
The risk or severity of CNS depression can be increased when Meprobamate is combined with Palonosetron.
Mepyramine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Mepyramine.
Mepyramine
The metabolism of Netupitant can be decreased when combined with Mepyramine.
Metamfetamine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Metamfetamine.
Metaxalone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Metaxalone.
Methadone
The metabolism of Methadone can be decreased when combined with Netupitant.
Methocarbamol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Methocarbamol.
Methohexital
The risk or severity of CNS depression can be increased when Palonosetron is combined with Methohexital.
Methsuximide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Methsuximide.
Methylene blue
The serum concentration of Methylene blue can be increased when it is combined with Netupitant.
Methylergometrine
The metabolism of Methylergometrine can be decreased when combined with Netupitant.
Methylprednisolone
The metabolism of Methylprednisolone can be decreased when combined with Netupitant.
Methyltestosterone
The metabolism of Methyltestosterone can be decreased when combined with Netupitant.
Metoclopramide
The risk or severity of sedation can be increased when Metoclopramide is combined with Palonosetron.
Metoclopramide
The metabolism of Metoclopramide can be decreased when combined with Netupitant.
Metoprolol
The metabolism of Palonosetron can be decreased when combined with Metoprolol.
Metoprolol
The metabolism of Netupitant can be decreased when combined with Metoprolol.
Metronidazole
The metabolism of Netupitant can be decreased when combined with Metronidazole.
Metyrapone
The metabolism of Netupitant can be increased when combined with Metyrapone.
Metyrosine
Palonosetron may increase the sedative activities of Metyrosine.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Netupitant.
Miconazole
The metabolism of Palonosetron can be decreased when combined with Miconazole.
Midazolam
The risk or severity of sedation and CNS depression can be increased when Midazolam is combined with Palonosetron.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Netupitant.
Mifepristone
The metabolism of Palonosetron can be decreased when combined with Mifepristone.
Mifepristone
The metabolism of Mifepristone can be decreased when combined with Netupitant.
Milnacipran
The risk or severity of adverse effects can be increased when Palonosetron is combined with Milnacipran.
Milnacipran
The metabolism of Netupitant can be decreased when combined with Milnacipran.
Mirabegron
The serum concentration of Palonosetron can be increased when it is combined with Mirabegron.
Mirabegron
The serum concentration of Netupitant can be increased when it is combined with Mirabegron.
Mirtazapine
The metabolism of Mirtazapine can be decreased when combined with Netupitant.
Mitapivat
The metabolism of Mitapivat can be decreased when combined with Netupitant.
Modafinil
The metabolism of Netupitant can be increased when combined with Modafinil.
Molindone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Molindone.
Mometasone furoate
The metabolism of Mometasone furoate can be decreased when combined with Netupitant.
Montelukast
The metabolism of Montelukast can be decreased when combined with Netupitant.
Morphine
The risk or severity of CNS depression can be increased when Morphine is combined with Palonosetron.
Morphine
The metabolism of Morphine can be decreased when combined with Netupitant.
Mycophenolate mofetil
The metabolism of Mycophenolate mofetil can be decreased when combined with Netupitant.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Nabilone
The metabolism of Nabilone can be decreased when combined with Netupitant.
Nafcillin
The metabolism of Netupitant can be increased when combined with Nafcillin.
Nalbuphine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Nalbuphine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Netupitant.
Naratriptan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Naratriptan.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Netupitant.
Nebivolol
The metabolism of Nebivolol can be decreased when combined with Netupitant.
Neomycin
Palonosetron may decrease the excretion rate of Neomycin which could result in a higher serum level.
Nevirapine
The metabolism of Nevirapine can be decreased when combined with Netupitant.
Niacin
The metabolism of Palonosetron can be decreased when combined with Niacin.
Niacin
The metabolism of Netupitant can be decreased when combined with Niacin.
Nicardipine
The metabolism of Palonosetron can be decreased when combined with Nicardipine.
Nicardipine
The metabolism of Netupitant can be decreased when combined with Nicardipine.
Nifedipine
The metabolism of Nifedipine can be decreased when combined with Netupitant.
Nilutamide
The metabolism of Netupitant can be decreased when combined with Nilutamide.
Nimodipine
The metabolism of Nimodipine can be decreased when combined with Netupitant.
Nintedanib
The metabolism of Nintedanib can be decreased when combined with Netupitant.
Nirmatrelvir
The metabolism of Nirmatrelvir can be decreased when combined with Netupitant.
Nirogacestat
The serum concentration of Nirogacestat can be increased when it is combined with Netupitant.
Nisoldipine
The metabolism of Nisoldipine can be decreased when combined with Netupitant.
Nitrous oxide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Nitrous oxide.
Norelgestromin
The metabolism of Norelgestromin can be decreased when combined with Netupitant.
Norethisterone
The metabolism of Norethisterone can be decreased when combined with Netupitant.
Norgestimate
The metabolism of Norgestimate can be decreased when combined with Netupitant.
Norgestrel
The metabolism of Norgestrel can be decreased when combined with Netupitant.
Octreotide
The metabolism of Netupitant can be decreased when combined with Octreotide.
Olanzapine
The risk or severity of CNS depression can be increased when Olanzapine is combined with Palonosetron.
Olaparib
The metabolism of Olaparib can be decreased when combined with Netupitant.
Oliceridine
The serum concentration of Oliceridine can be increased when it is combined with Netupitant.
Olutasidenib
The metabolism of Olutasidenib can be decreased when combined with Netupitant.
Omadacycline
The serum concentration of Omadacycline can be increased when it is combined with Netupitant.
Ombitasvir
The serum concentration of Ombitasvir can be increased when it is combined with Netupitant.
Ondansetron
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ondansetron.
Ondansetron
The metabolism of Ondansetron can be decreased when combined with Netupitant.
Opium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Opium.
Opium
The metabolism of Opium can be decreased when combined with Netupitant.
Oritavancin
The metabolism of Netupitant can be increased when combined with Oritavancin.
Orphenadrine
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osilodrostat
The metabolism of Osilodrostat can be decreased when combined with Netupitant.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Netupitant.
Oxandrolone
The metabolism of Netupitant can be decreased when combined with Oxandrolone.
Oxazepam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxazepam.
Oxcarbazepine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxcarbazepine.
Oxcarbazepine
The metabolism of Netupitant can be increased when combined with Oxcarbazepine.
Oxybuprocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxybuprocaine.
Oxybutynin
The metabolism of Palonosetron can be decreased when combined with Oxybutynin.
Oxybutynin
The metabolism of Oxybutynin can be decreased when combined with Netupitant.
Oxycodone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxycodone.
Oxycodone
The metabolism of Oxycodone can be decreased when combined with Netupitant.
Oxymorphone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxymorphone.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Netupitant.
Paliperidone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Paliperidone.
Paliperidone
The metabolism of Paliperidone can be decreased when combined with Netupitant.
Palovarotene
The serum concentration of Palovarotene can be increased when it is combined with Netupitant.
Pancuronium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pancuronium.
Panobinostat
The metabolism of Palonosetron can be decreased when combined with Panobinostat.
Panobinostat
The metabolism of Netupitant can be decreased when combined with Panobinostat.
Pantoprazole
The metabolism of Pantoprazole can be decreased when combined with Netupitant.
Parecoxib
The metabolism of Parecoxib can be decreased when combined with Netupitant.
Paricalcitol
The metabolism of Paricalcitol can be decreased when combined with Netupitant.
Paritaprevir
The metabolism of Paritaprevir can be decreased when combined with Netupitant.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Netupitant.
Pemetrexed
Palonosetron may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Pemigatinib
The metabolism of Pemigatinib can be decreased when combined with Netupitant.
Pentazocine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pentazocine.
Pentostatin
Palonosetron may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Perampanel
The metabolism of Perampanel can be decreased when combined with Netupitant.
Pergolide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pergolide.
Perphenazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Perphenazine.
Perphenazine
The metabolism of Netupitant can be decreased when combined with Perphenazine.
Phenelzine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Phenelzine.
Phentermine
The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Palonosetron.
Phentermine
The metabolism of Phentermine can be decreased when combined with Netupitant.
Phenylbutyric acid
The metabolism of Palonosetron can be decreased when combined with Phenylbutyric acid.
Phenylbutyric acid
The metabolism of Netupitant can be decreased when combined with Phenylbutyric acid.
Phenytoin
The metabolism of Netupitant can be increased when combined with Phenytoin.
Pibrentasvir
The serum concentration of Pibrentasvir can be increased when it is combined with Netupitant.
Pinaverium
The metabolism of Pinaverium can be decreased when combined with Netupitant.
Pindolol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pindolol.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Netupitant.
Piperine
The metabolism of Netupitant can be decreased when combined with Piperine.
Pirtobrutinib
The metabolism of Pirtobrutinib can be decreased when combined with Netupitant.
Pitolisant
The serum concentration of Palonosetron can be decreased when it is combined with Pitolisant.
Pitolisant
The serum concentration of Netupitant can be decreased when it is combined with Pitolisant.
Plazomicin
Palonosetron may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Polatuzumab vedotin
The metabolism of Polatuzumab vedotin can be decreased when combined with Netupitant.
Pomalidomide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pomalidomide.
Ponesimod
The metabolism of Ponesimod can be decreased when combined with Netupitant.
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Netupitant.
Pramipexole
Palonosetron may increase the sedative activities of Pramipexole.
Pramocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pramocaine.
Prasterone
The metabolism of Prasterone can be decreased when combined with Netupitant.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Netupitant.
Praziquantel
The metabolism of Praziquantel can be decreased when combined with Netupitant.
Prednisolone
The metabolism of Prednisolone can be decreased when combined with Netupitant.
Prednisolone acetate
The metabolism of Prednisolone acetate can be decreased when combined with Netupitant.
Prednisolone phosphate
The metabolism of Prednisolone phosphate can be decreased when combined with Netupitant.
Prednisone
The metabolism of Prednisone can be decreased when combined with Netupitant.
Pregabalin
The therapeutic efficacy of Palonosetron can be increased when used in combination with Pregabalin.
Pregnenolone
The metabolism of Pregnenolone can be decreased when combined with Netupitant.
Prilocaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Prilocaine.
Primaquine
The metabolism of Palonosetron can be decreased when combined with Primaquine.
Primaquine
The metabolism of Netupitant can be decreased when combined with Primaquine.
Probenecid
The metabolism of Netupitant can be increased when combined with Probenecid.
Procaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Procaine.
Procarbazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Procarbazine.
Prochlorperazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Prochlorperazine.
Prochlorperazine
The metabolism of Prochlorperazine can be decreased when combined with Netupitant.
Progesterone
The metabolism of Progesterone can be decreased when combined with Netupitant.
Promethazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Promethazine.
Promethazine
The metabolism of Netupitant can be decreased when combined with Promethazine.
Propofol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Propofol.
Propranolol
The metabolism of Propranolol can be decreased when combined with Netupitant.
Protriptyline
The risk or severity of CNS depression can be increased when Protriptyline is combined with Palonosetron.
Prucalopride
The serum concentration of Prucalopride can be increased when it is combined with Netupitant.
Pseudoephedrine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Pseudoephedrine.
Pyrantel
The risk or severity of CNS depression can be increased when Palonosetron is combined with Pyrantel.
Quazepam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Quazepam.
Quazepam
The metabolism of Quazepam can be decreased when combined with Netupitant.
Quetiapine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Quetiapine.
Quetiapine
The metabolism of Quetiapine can be decreased when combined with Netupitant.
Quinine
The metabolism of Palonosetron can be decreased when combined with Quinine.
Quinine
The metabolism of Netupitant can be decreased when combined with Quinine.
Quizartinib
The metabolism of Quizartinib can be decreased when combined with Netupitant.
Raloxifene
The metabolism of Netupitant can be decreased when combined with Raloxifene.
Ramelteon
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ramelteon.
Ramelteon
The metabolism of Ramelteon can be decreased when combined with Netupitant.
Ranitidine
The metabolism of Palonosetron can be decreased when combined with Ranitidine.
Ranitidine
The metabolism of Netupitant can be decreased when combined with Ranitidine.
Ranolazine
The serum concentration of Palonosetron can be increased when it is combined with Ranolazine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Netupitant.
Rasagiline
The risk or severity of CNS depression can be increased when Palonosetron is combined with Rasagiline.
Relugolix
The serum concentration of Relugolix can be increased when it is combined with Netupitant.
Remdesivir
The metabolism of Remdesivir can be decreased when combined with Netupitant.
Remifentanil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Remifentanil.
Remimazolam
The risk or severity of sedation can be increased when Palonosetron is combined with Remimazolam.
Repaglinide
The metabolism of Repaglinide can be decreased when combined with Netupitant.
Repotrectinib
The serum concentration of Repotrectinib can be increased when it is combined with Netupitant.
Reserpine
The risk or severity of CNS depression can be increased when Reserpine is combined with Palonosetron.
Retapamulin
The metabolism of Retapamulin can be decreased when combined with Netupitant.
Revefenacin
The serum concentration of Revefenacin can be increased when it is combined with Netupitant.
Revumenib
The metabolism of Revumenib can be decreased when combined with Netupitant.
Rifabutin
The metabolism of Rifabutin can be decreased when combined with Netupitant.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Netupitant.
Rilonacept
The metabolism of Palonosetron can be increased when combined with Rilonacept.
Rilonacept
The metabolism of Netupitant can be increased when combined with Rilonacept.
Rilpivirine
The metabolism of Palonosetron can be decreased when combined with Rilpivirine.
Rilpivirine
The metabolism of Rilpivirine can be decreased when combined with Netupitant.
Riluzole
The risk or severity of CNS depression can be increased when Palonosetron is combined with Riluzole.
Rilzabrutinib
The metabolism of Rilzabrutinib can be decreased when combined with Netupitant.
Riociguat
The metabolism of Riociguat can be decreased when combined with Netupitant.
Ripretinib
The metabolism of Ripretinib can be decreased when combined with Netupitant.
Risperidone
The risk or severity of CNS depression can be increased when Palonosetron is combined with Risperidone.
Risperidone
The metabolism of Risperidone can be decreased when combined with Netupitant.
Ritlecitinib
The serum concentration of Palonosetron can be increased when it is combined with Ritlecitinib.
Ritlecitinib
The serum concentration of Netupitant can be increased when it is combined with Ritlecitinib.
Ritonavir
The serum concentration of Palonosetron can be increased when it is combined with Ritonavir.
Ritonavir
The serum concentration of Netupitant can be increased when it is combined with Ritonavir.
Rivaroxaban
The metabolism of Rivaroxaban can be decreased when combined with Netupitant.
Rizatriptan
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Rizatriptan.
Rocuronium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Rocuronium.
Roflumilast
The serum concentration of Roflumilast can be increased when it is combined with Netupitant.
Rolapitant
The metabolism of Palonosetron can be decreased when combined with Rolapitant.
Rolapitant
The metabolism of Netupitant can be decreased when combined with Rolapitant.
Ropeginterferon alfa-2b
The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Palonosetron.
Ropeginterferon alfa-2b
The metabolism of Netupitant can be decreased when combined with Ropeginterferon alfa-2b.
Ropinirole
Palonosetron may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of CNS depression can be increased when Ropivacaine is combined with Palonosetron.
Rosiglitazone
The metabolism of Rosiglitazone can be decreased when combined with Netupitant.
Rosuvastatin
The metabolism of Rosuvastatin can be decreased when combined with Netupitant.
Rotigotine
Palonosetron may increase the sedative activities of Rotigotine.
Rotigotine
The metabolism of Rotigotine can be decreased when combined with Netupitant.
Rucaparib
The metabolism of Palonosetron can be decreased when combined with Rucaparib.
Rucaparib
The metabolism of Netupitant can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Palonosetron.
Rufinamide
The metabolism of Netupitant can be increased when combined with Rufinamide.
Safinamide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Safinamide.
Safinamide
The metabolism of Safinamide can be decreased when combined with Netupitant.
Salmeterol
The metabolism of Salmeterol can be decreased when combined with Netupitant.
Samidorphan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Samidorphan.
Samidorphan
The metabolism of Samidorphan can be decreased when combined with Netupitant.
Sarilumab
The metabolism of Netupitant can be increased when combined with Sarilumab.
Satralizumab
The serum concentration of Palonosetron can be decreased when it is combined with Satralizumab.
Satralizumab
The serum concentration of Netupitant can be decreased when it is combined with Satralizumab.
Saxagliptin
The metabolism of Saxagliptin can be decreased when combined with Netupitant.
Scopolamine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Scopolamine.
Scopolamine
The metabolism of Scopolamine can be decreased when combined with Netupitant.
Sebetralstat
The metabolism of Sebetralstat can be decreased when combined with Netupitant.
Secobarbital
The risk or severity of CNS depression can be increased when Palonosetron is combined with Secobarbital.
Secobarbital
The metabolism of Netupitant can be increased when combined with Secobarbital.
Secukinumab
The metabolism of Palonosetron can be increased when combined with Secukinumab.
Secukinumab
The metabolism of Netupitant can be increased when combined with Secukinumab.
Selegiline
The risk or severity of CNS depression can be increased when Palonosetron is combined with Selegiline.
Selegiline
The metabolism of Selegiline can be decreased when combined with Netupitant.
Selexipag
The metabolism of Selexipag can be decreased when combined with Netupitant.
Selinexor
The metabolism of Selinexor can be decreased when combined with Netupitant.
Selpercatinib
The metabolism of Selpercatinib can be decreased when combined with Netupitant.
Sertraline
The risk or severity of adverse effects can be increased when Palonosetron is combined with Sertraline.
Sertraline
The metabolism of Sertraline can be decreased when combined with Netupitant.
Sevoflurane
The risk or severity of CNS depression can be increased when Palonosetron is combined with Sevoflurane.
Sildenafil
The metabolism of Sildenafil can be decreased when combined with Netupitant.
Siltuximab
The metabolism of Palonosetron can be increased when combined with Siltuximab.
Siltuximab
The metabolism of Netupitant can be increased when combined with Siltuximab.
Simvastatin
The metabolism of Simvastatin can be decreased when combined with Netupitant.
Sitagliptin
The metabolism of Sitagliptin can be decreased when combined with Netupitant.
Sofosbuvir
The serum concentration of Sofosbuvir can be increased when it is combined with Netupitant.
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Netupitant.
Solriamfetol
The risk or severity of CNS depression can be increased when Palonosetron is combined with Solriamfetol.
Sonidegib
The metabolism of Sonidegib can be decreased when combined with Netupitant.
Sotorasib
The serum concentration of Palonosetron can be decreased when it is combined with Sotorasib.
Sotorasib
The serum concentration of Netupitant can be decreased when it is combined with Sotorasib.
Sparsentan
The serum concentration of Netupitant can be decreased when it is combined with Sparsentan.
Stiripentol
The metabolism of Palonosetron can be decreased when combined with Stiripentol.
Stiripentol
The metabolism of Netupitant can be decreased when combined with Stiripentol.
Streptomycin
Palonosetron may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Succinylcholine
The risk or severity of CNS depression can be increased when Succinylcholine is combined with Palonosetron.
Sufentanil
The risk or severity of CNS depression can be increased when Palonosetron is combined with Sufentanil.
Sufentanil
The metabolism of Sufentanil can be decreased when combined with Netupitant.
Sulfadiazine
The metabolism of Sulfadiazine can be decreased when combined with Netupitant.
Sulfamethizole
The metabolism of Netupitant can be decreased when combined with Sulfamethizole.
Sulfamethoxazole
The metabolism of Netupitant can be decreased when combined with Sulfamethoxazole.
Sumatriptan
The risk or severity of CNS depression can be increased when Palonosetron is combined with Sumatriptan.
Sunitinib
The risk or severity of QTc prolongation and torsade de pointes can be increased when Sunitinib is combined with Palonosetron.
Suvorexant
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Suvorexant
The metabolism of Suvorexant can be decreased when combined with Netupitant.
Suzetrigine
The metabolism of Suzetrigine can be decreased when combined with Netupitant.
Synthetic Conjugated Estrogens, A
The metabolism of Synthetic Conjugated Estrogens, A can be decreased when combined with Netupitant.
Synthetic Conjugated Estrogens, B
The metabolism of Synthetic Conjugated Estrogens, B can be decreased when combined with Netupitant.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Netupitant.
Tadalafil
The metabolism of Tadalafil can be decreased when combined with Netupitant.
Taletrectinib
The metabolism of Taletrectinib can be decreased when combined with Netupitant.
Tamsulosin
The metabolism of Tamsulosin can be decreased when combined with Netupitant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Tasimelteon
The risk or severity of CNS depression can be increased when Palonosetron is combined with Tasimelteon.
Tasimelteon
The metabolism of Tasimelteon can be decreased when combined with Netupitant.
Tazemetostat
The metabolism of Tazemetostat can be decreased when combined with Netupitant.
Technetium Tc-99m sestamibi
The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Netupitant.
Tecovirimat
The metabolism of Netupitant can be increased when combined with Tecovirimat.
Tegaserod
The metabolism of Palonosetron can be decreased when combined with Tegaserod.
Tegaserod
The metabolism of Netupitant can be decreased when combined with Tegaserod.
Telotristat ethyl
The serum concentration of Palonosetron can be decreased when it is combined with Telotristat ethyl.
Telotristat ethyl
The serum concentration of Netupitant can be decreased when it is combined with Telotristat ethyl.
Temazepam
The risk or severity of CNS depression can be increased when Temazepam is combined with Palonosetron.
Tenofovir alafenamide
The serum concentration of Tenofovir alafenamide can be increased when it is combined with Palonosetron.
Tenofovir alafenamide
The serum concentration of Tenofovir alafenamide can be increased when it is combined with Netupitant.
Tenofovir disoproxil
The serum concentration of Tenofovir disoproxil can be increased when it is combined with Netupitant.
Terbinafine
The metabolism of Palonosetron can be decreased when combined with Terbinafine.
Terbinafine
The metabolism of Netupitant can be decreased when combined with Terbinafine.
Testosterone
The metabolism of Testosterone can be decreased when combined with Netupitant.
Testosterone cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Netupitant.
Testosterone enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Netupitant.
Testosterone propionate
The metabolism of Testosterone propionate can be decreased when combined with Netupitant.
Tetracaine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Tetracaine.
Tetracycline
The metabolism of Tetracycline can be decreased when combined with Netupitant.
Tezacaftor
The metabolism of Tezacaftor can be decreased when combined with Netupitant.
Thalidomide
The metabolism of Thalidomide can be decreased when combined with Netupitant.
Thiothixene
The risk or severity of CNS depression can be increased when Palonosetron is combined with Thiothixene.
Tiagabine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Tiagabine.
Tiagabine
The metabolism of Tiagabine can be decreased when combined with Netupitant.
Ticagrelor
The metabolism of Ticagrelor can be decreased when combined with Netupitant.
Ticlopidine
The metabolism of Palonosetron can be decreased when combined with Ticlopidine.
Ticlopidine
The metabolism of Netupitant can be decreased when combined with Ticlopidine.
Tinidazole
The metabolism of Tinidazole can be decreased when combined with Netupitant.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Netupitant.
Tisotumab vedotin
The metabolism of Tisotumab vedotin can be decreased when combined with Netupitant.
Tivozanib
The serum concentration of Tivozanib can be increased when it is combined with Netupitant.
Tizanidine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Tizanidine.
Tobramycin
Palonosetron may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tocilizumab
The metabolism of Palonosetron can be increased when combined with Tocilizumab.
Tocilizumab
The metabolism of Netupitant can be increased when combined with Tocilizumab.
Tocofersolan
The metabolism of Tocofersolan can be decreased when combined with Netupitant.
Tocopherol
The metabolism of Tocopherol can be decreased when combined with Netupitant.
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Netupitant.
Tolcapone
The risk or severity of CNS depression can be increased when Tolcapone is combined with Palonosetron.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Netupitant.
Topiramate
The risk or severity of CNS depression can be increased when Topiramate is combined with Palonosetron.
Topiramate
The metabolism of Netupitant can be increased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Netupitant.
Torasemide
The metabolism of Netupitant can be decreased when combined with Torasemide.
Toremifene
The metabolism of Toremifene can be decreased when combined with Netupitant.
Tovorafenib
The metabolism of Netupitant can be increased when combined with Tovorafenib.
Tramadol
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Tramadol.
Tramadol
The metabolism of Tramadol can be decreased when combined with Netupitant.
Tranylcypromine
The metabolism of Palonosetron can be decreased when combined with Tranylcypromine.
Tranylcypromine
The metabolism of Netupitant can be decreased when combined with Tranylcypromine.
Trazodone
The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Palonosetron.
Trazodone
The metabolism of Trazodone can be decreased when combined with Netupitant.
Treosulfan
The metabolism of Netupitant can be decreased when combined with Treosulfan.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Netupitant.
Triamcinolone
The metabolism of Triamcinolone can be decreased when combined with Netupitant.
Triazolam
The risk or severity of CNS depression can be increased when Palonosetron is combined with Triazolam.
Triazolam
The metabolism of Triazolam can be decreased when combined with Netupitant.
Triclabendazole
The metabolism of Palonosetron can be decreased when combined with Triclabendazole.
Triclabendazole
The metabolism of Triclabendazole can be decreased when combined with Netupitant.
Trifluoperazine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Trifluoperazine.
Trilaciclib
The serum concentration of Trilaciclib can be increased when it is combined with Netupitant.
Trimethobenzamide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Trimethobenzamide.
Trimethoprim
The metabolism of Trimethoprim can be decreased when combined with Netupitant.
Triprolidine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Triprolidine.
Tryptophan
The risk or severity of CNS depression can be increased when Tryptophan is combined with Palonosetron.
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Palonosetron.
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Netupitant.
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Netupitant.
Ulipristal
The metabolism of Ulipristal can be decreased when combined with Netupitant.
Umeclidinium
The serum concentration of Umeclidinium can be increased when it is combined with Netupitant.
Upadacitinib
The metabolism of Upadacitinib can be decreased when combined with Netupitant.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Netupitant.
Valdecoxib
The metabolism of Valdecoxib can be decreased when combined with Netupitant.
Valproic acid
The risk or severity of CNS depression can be increased when Valproic acid is combined with Palonosetron.
Valproic acid
The metabolism of Netupitant can be decreased when combined with Valproic acid.
Valsartan
The metabolism of Netupitant can be decreased when combined with Valsartan.
Vamorolone
The metabolism of Vamorolone can be decreased when combined with Netupitant.
Vancomycin
Palonosetron may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Vardenafil
The metabolism of Vardenafil can be decreased when combined with Netupitant.
Vecuronium
The risk or severity of CNS depression can be increased when Palonosetron is combined with Vecuronium.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Netupitant.
Venetoclax
The metabolism of Palonosetron can be decreased when combined with Venetoclax.
Venlafaxine
The metabolism of Venlafaxine can be decreased when combined with Netupitant.
Verapamil
The metabolism of Palonosetron can be decreased when combined with Verapamil.
Verapamil
The metabolism of Netupitant can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of CNS depression can be increased when Palonosetron is combined with Vigabatrin.
Vilanterol
The metabolism of Vilanterol can be decreased when combined with Netupitant.
Vilazodone
The metabolism of Palonosetron can be decreased when combined with Vilazodone.
Vilazodone
The metabolism of Netupitant can be decreased when combined with Vilazodone.
Vincristine
The excretion of Vincristine can be decreased when combined with Netupitant.
Vitamin D
The metabolism of Vitamin D can be decreased when combined with Netupitant.
Vitamin E
The metabolism of Vitamin E can be decreased when combined with Netupitant.
Voclosporin
The metabolism of Voclosporin can be decreased when combined with Netupitant.
Vonoprazan
The metabolism of Vonoprazan can be decreased when combined with Netupitant.
Vorapaxar
The metabolism of Vorapaxar can be decreased when combined with Netupitant.
Vorasidenib
The metabolism of Netupitant can be increased when combined with Vorasidenib.
Vortioxetine
The risk or severity of CNS depression can be increased when Palonosetron is combined with Vortioxetine.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Netupitant.
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Netupitant.
Voxilaprevir
The metabolism of Voxilaprevir can be decreased when combined with Netupitant.
Warfarin
Palonosetron may decrease the excretion rate of Warfarin which could result in a higher serum level.
Warfarin
The serum concentration of Warfarin can be increased when it is combined with Netupitant.
Zafirlukast
The metabolism of Netupitant can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of CNS depression can be increased when Palonosetron is combined with Zaleplon.
Zaleplon
The metabolism of Zaleplon can be decreased when combined with Netupitant.
Zanubrutinib
The metabolism of Zanubrutinib can be decreased when combined with Netupitant.
Ziconotide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Ziconotide.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Netupitant.
Zileuton
The metabolism of Zileuton can be decreased when combined with Netupitant.
Ziprasidone
The risk or severity of adverse effects can be increased when Palonosetron is combined with Ziprasidone.
Ziprasidone
The metabolism of Netupitant can be decreased when combined with Ziprasidone.
Zolmitriptan
The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Palonosetron.
Zolpidem
Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Netupitant.
Zonisamide
The risk or severity of CNS depression can be increased when Palonosetron is combined with Zonisamide.
Zonisamide
The metabolism of Zonisamide can be decreased when combined with Netupitant.
Zuranolone
The risk or severity of CNS depression can be increased when Zuranolone is combined with Palonosetron.
Zuranolone
The metabolism of Zuranolone can be decreased when combined with Netupitant.
Abacavir
Palonosetron may decrease the excretion rate of Abacavir which could result in a higher serum level.
Abrocitinib
The metabolism of Abrocitinib can be decreased when combined with Netupitant.
Aceclofenac
Aceclofenac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Acenocoumarol
The risk or severity of adverse effects can be increased when Palonosetron is combined with Acenocoumarol.
Acetaminophen
Acetaminophen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Acetyl sulfisoxazole
The metabolism of Netupitant can be decreased when combined with Acetyl sulfisoxazole.
Acetylsalicylic acid
Acetylsalicylic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Acetylsalicylic acid
The metabolism of Netupitant can be decreased when combined with Acetylsalicylic acid.
Aclidinium
Palonosetron may decrease the excretion rate of Aclidinium which could result in a higher serum level.
Acrivastine
Palonosetron may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Acyclovir
Acyclovir may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Adefovir dipivoxil
Adefovir dipivoxil may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Albuterol
Palonosetron may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Albutrepenonacog alfa
Palonosetron may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Aldesleukin
Aldesleukin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Allopurinol
Palonosetron may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Almasilate
Palonosetron may decrease the excretion rate of Almasilate which could result in a higher serum level.
Alogliptin
Palonosetron may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Amiloride
Amiloride may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Ammonium chloride
Palonosetron may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
Amoxicillin
Palonosetron may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Amphetamine
The metabolism of Netupitant can be decreased when combined with Amphetamine.
Amphotericin B
Amphotericin B may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ampicillin
Palonosetron may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Antipyrine
Antipyrine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Antithrombin III human
Palonosetron may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
Arformoterol
Palonosetron may decrease the excretion rate of Arformoterol which could result in a higher serum level.
Arformoterol
The metabolism of Netupitant can be decreased when combined with Arformoterol.
Arsenic trioxide
Palonosetron may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Atenolol
The metabolism of Palonosetron can be decreased when combined with Atenolol.
Atenolol
The metabolism of Netupitant can be decreased when combined with Atenolol.
Atomoxetine
Atomoxetine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Atomoxetine
The metabolism of Netupitant can be decreased when combined with Atomoxetine.
Auranofin
Palonosetron may decrease the excretion rate of Auranofin which could result in a higher serum level.
Azacitidine
Palonosetron may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Azathioprine
Palonosetron may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Azelaic acid
Palonosetron may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
Aztreonam
Aztreonam may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Bacitracin
Bacitracin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Baclofen
Baclofen may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Balsalazide
Balsalazide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Baricitinib
Palonosetron may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bendroflumethiazide
Bendroflumethiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Benzatropine
Benzatropine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Benzatropine
The metabolism of Netupitant can be decreased when combined with Benzatropine.
Benznidazole
Palonosetron may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Benzocaine
The metabolism of Netupitant can be decreased when combined with Benzocaine.
Benzyl alcohol
The metabolism of Netupitant can be decreased when combined with Benzyl alcohol.
Bepotastine
Palonosetron may decrease the excretion rate of Bepotastine which could result in a higher serum level.
Betaxolol
The metabolism of Palonosetron can be decreased when combined with Betaxolol.
Betaxolol
The metabolism of Netupitant can be decreased when combined with Betaxolol.
Bicisate
Palonosetron may decrease the excretion rate of Bicisate which could result in a higher serum level.
Bismuth subgallate
Palonosetron may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
Bisoprolol
Palonosetron may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Bleomycin
Bleomycin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Bortezomib
The metabolism of Palonosetron can be decreased when combined with Bortezomib.
Bromotheophylline
Bromotheophylline may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Budesonide
Palonosetron may decrease the excretion rate of Budesonide which could result in a higher serum level.
Bumetanide
Bumetanide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Canagliflozin
Palonosetron may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Candesartan cilexetil
The metabolism of Netupitant can be decreased when combined with Candesartan cilexetil.
Capecitabine
Palonosetron may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Carbidopa
Carbidopa may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Carboplatin
Carboplatin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Carmustine
Carmustine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Palonosetron.
Cefaclor
Cefaclor may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefadroxil
Cefadroxil may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefazolin
Cefazolin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefdinir
Palonosetron may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cefditoren
Cefditoren may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefepime
Cefepime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefotaxime
Cefotaxime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefotetan
Cefotetan may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefoxitin
Cefoxitin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefpodoxime
Cefpodoxime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefprozil
Cefprozil may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ceftaroline fosamil
Ceftaroline fosamil may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ceftazidime
Ceftazidime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ceftibuten
Ceftibuten may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ceftizoxime
Ceftizoxime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ceftolozane
Palonosetron may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
Ceftriaxone
Ceftriaxone may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cefuroxime
Cefuroxime may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cephalexin
Cephalexin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cevimeline
Cevimeline may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Chlorothiazide
Chlorothiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone
Chlorthalidone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Choline salicylate
Palonosetron may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
Chondroitin sulfate
Palonosetron may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
Chromic chloride
Palonosetron may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
Chromium
Palonosetron may decrease the excretion rate of Chromium which could result in a higher serum level.
Chromium nicotinate
Palonosetron may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
Ciclesonide
The metabolism of Ciclesonide can be decreased when combined with Palonosetron.
Cidofovir
Cidofovir may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cilostazol
Palonosetron may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Cimetidine
Palonosetron may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Clevidipine
Palonosetron may decrease the excretion rate of Clevidipine which could result in a higher serum level.
Clofarabine
Palonosetron may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Clove oil
Palonosetron may decrease the excretion rate of Clove oil which could result in a higher serum level.
Cobicistat
The metabolism of Palonosetron can be decreased when combined with Cobicistat.
Colchicine
Palonosetron may decrease the excretion rate of Colchicine which could result in a higher serum level.
Colistimethate
Colistimethate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Conjugated estrogens
Conjugated estrogens may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Cyanocobalamin
Cyanocobalamin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Dabigatran etexilate
Palonosetron may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
Dacarbazine
Palonosetron may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Dalfampridine
Palonosetron may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Dalfopristin
The metabolism of Netupitant can be decreased when combined with Dalfopristin.
Daptomycin
Daptomycin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Daridorexant
The risk or severity of CNS depression can be increased when Palonosetron is combined with Daridorexant.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Palonosetron.
Deferiprone
Palonosetron may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Delafloxacin
Palonosetron may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Delafloxacin
The metabolism of Netupitant can be increased when combined with Delafloxacin.
Desmopressin
Desmopressin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Desvenlafaxine
The serum concentration of Netupitant can be increased when it is combined with Desvenlafaxine.
Deutetrabenazine
Palonosetron may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Dexamethasone
The metabolism of Dexamethasone can be decreased when combined with Netupitant.
Dexpanthenol
Palonosetron may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
Dexrazoxane
Palonosetron may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Dextran
Palonosetron may decrease the excretion rate of Dextran which could result in a higher serum level.
Dextroamphetamine
The metabolism of Netupitant can be decreased when combined with Dextroamphetamine.
Diatrizoate
Diatrizoate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Diclofenac
Diclofenac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Diclofenamide
Diclofenamide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Dicyclomine
Palonosetron may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Didanosine
Palonosetron may decrease the excretion rate of Didanosine which could result in a higher serum level.
Dienogest
Palonosetron may decrease the excretion rate of Dienogest which could result in a higher serum level.
Diflunisal
Diflunisal may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Dimercaprol
Palonosetron may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
Disopyramide
Disopyramide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DL-Methylephedrine
Palonosetron may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
Dobutamine
Palonosetron may decrease the excretion rate of Dobutamine which could result in a higher serum level.
Dopamine
Palonosetron may decrease the excretion rate of Dopamine which could result in a higher serum level.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Palonosetron.
Doxycycline
Doxycycline may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Dronedarone
The metabolism of Palonosetron can be decreased when combined with Dronedarone.
Dronedarone
The metabolism of Netupitant can be decreased when combined with Dronedarone.
Drospirenone
Drospirenone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Droxidopa
Palonosetron may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Edoxaban
Palonosetron may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Edrophonium
Palonosetron may decrease the excretion rate of Edrophonium which could result in a higher serum level.
Elagolix
The metabolism of Elagolix can be decreased when combined with Palonosetron.
Enalaprilat
Palonosetron may decrease the excretion rate of Enalaprilat which could result in a higher serum level.
Ensartinib
The serum concentration of Ensartinib can be increased when it is combined with Netupitant.
Entacapone
The metabolism of Netupitant can be decreased when combined with Entacapone.
Eplerenone
Eplerenone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Epoprostenol
Palonosetron may decrease the excretion rate of Epoprostenol which could result in a higher serum level.
Ertapenem
Ertapenem may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Esmolol
The metabolism of Palonosetron can be decreased when combined with Esmolol.
Esmolol
The metabolism of Netupitant can be decreased when combined with Esmolol.
Estradiol
Palonosetron may decrease the excretion rate of Estradiol which could result in a higher serum level.
Estradiol acetate
Palonosetron may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
Estradiol cypionate
Palonosetron may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
Estradiol valerate
Palonosetron may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
Estrone sulfate
Palonosetron may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
Etacrynic acid
Etacrynic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ethambutol
Ethambutol may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ethambutol
The metabolism of Netupitant can be decreased when combined with Ethambutol.
Ethenzamide
Ethenzamide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Etodolac
Etodolac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Etodolac
The metabolism of Netupitant can be decreased when combined with Etodolac.
Etonogestrel
Etonogestrel may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Eucalyptus oil
Palonosetron may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
Evening primrose oil
Palonosetron may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
Fenofibrate
Palonosetron may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Fenofibric acid
Palonosetron may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
Fenoldopam
Palonosetron may decrease the excretion rate of Fenoldopam which could result in a higher serum level.
Fenoprofen
Fenoprofen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Fesoterodine
Palonosetron may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Fexinidazole
The metabolism of Fexinidazole can be decreased when combined with Palonosetron.
Finerenone
Finerenone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Flavoxate
Palonosetron may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Florbetaben F-18
Palonosetron may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
Florbetapir F-18
Palonosetron may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
Floxuridine
Floxuridine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Flucytosine
Palonosetron may decrease the excretion rate of Flucytosine which could result in a higher serum level.
Fludeoxyglucose (18F)
Palonosetron may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
Flumazenil
Palonosetron may decrease the excretion rate of Flumazenil which could result in a higher serum level.
Fluocinolone acetonide
Palonosetron may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.
Fluphenazine
The metabolism of Netupitant can be decreased when combined with Fluphenazine.
Flurbiprofen
Flurbiprofen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Flurbiprofen
The metabolism of Netupitant can be decreased when combined with Flurbiprofen.
Flutamide
Palonosetron may decrease the excretion rate of Flutamide which could result in a higher serum level.
Fluvastatin
The metabolism of Fluvastatin can be decreased when combined with Palonosetron.
Folic acid
Folic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Fomepizole
Palonosetron may decrease the excretion rate of Fomepizole which could result in a higher serum level.
Fondaparinux
Palonosetron may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Formoterol
The metabolism of Formoterol can be decreased when combined with Palonosetron.
Formoterol
The metabolism of Netupitant can be decreased when combined with Formoterol.
Foscarnet
Foscarnet may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Fosfomycin
Palonosetron may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Fosinopril
Palonosetron may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Furosemide
Furosemide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Gadobenic acid
Palonosetron may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
Gadodiamide
Gadodiamide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Gadofosveset trisodium
Palonosetron may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
Gadoteric acid
Palonosetron may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
Gadoteridol
Palonosetron may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
Galantamine
The metabolism of Galantamine can be decreased when combined with Palonosetron.
Ganciclovir
Palonosetron may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Gefitinib
The metabolism of Palonosetron can be decreased when combined with Gefitinib.
Gemcitabine
Palonosetron may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Gemfibrozil
Palonosetron may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Glimepiride
The metabolism of Netupitant can be decreased when combined with Glimepiride.
Glipizide
Palonosetron may decrease the excretion rate of Glipizide which could result in a higher serum level.
Glipizide
The metabolism of Netupitant can be decreased when combined with Glipizide.
Golodirsen
Palonosetron may decrease the excretion rate of Golodirsen which could result in a higher serum level.
Goserelin
Goserelin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Hydralazine
Palonosetron may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Hydrochlorothiazide
Hydrochlorothiazide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Hydroflumethiazide
Hydroflumethiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Hydromorphone
The metabolism of Netupitant can be decreased when combined with Hydromorphone.
Hydroxocobalamin
Hydroxocobalamin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Hydroxyethyl Starch
Palonosetron may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Palonosetron.
Ibuprofen
Ibuprofen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ibutilide
Ibutilide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Icatibant
Palonosetron may decrease the excretion rate of Icatibant which could result in a higher serum level.
Icosapent
Icosapent may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Idarubicin
The metabolism of Idarubicin can be decreased when combined with Palonosetron.
Idarubicin
The metabolism of Netupitant can be decreased when combined with Idarubicin.
Idarucizumab
Palonosetron may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
Ifosfamide
Palonosetron may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Imatinib
The serum concentration of Palonosetron can be increased when it is combined with Imatinib.
Imatinib
The serum concentration of Netupitant can be increased when it is combined with Imatinib.
Indapamide
Palonosetron may decrease the excretion rate of Indapamide which could result in a higher serum level.
Indigotindisulfonic acid
Palonosetron may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
Indomethacin
Indomethacin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Indomethacin
The metabolism of Netupitant can be decreased when combined with Indomethacin.
Inositol
Palonosetron may decrease the excretion rate of Inositol which could result in a higher serum level.
Inotersen
Inotersen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Iobenguane sulfate I-123
Palonosetron may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
Iodixanol
Palonosetron may decrease the excretion rate of Iodixanol which could result in a higher serum level.
Ioflupane I-123
Palonosetron may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
Iopromide
Palonosetron may decrease the excretion rate of Iopromide which could result in a higher serum level.
Iothalamic acid
Palonosetron may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
Ioversol
Palonosetron may decrease the excretion rate of Ioversol which could result in a higher serum level.
Ipecac
Palonosetron may decrease the excretion rate of Ipecac which could result in a higher serum level.
Ipilimumab
Palonosetron may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Iptacopan
The metabolism of Iptacopan can be decreased when combined with Palonosetron.
Iptacopan
The metabolism of Iptacopan can be decreased when combined with Netupitant.
Isosorbide
Isosorbide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide mononitrate
Palonosetron may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
Isosulfan blue
Palonosetron may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
Isotretinoin
Palonosetron may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Istradefylline
The metabolism of Istradefylline can be decreased when combined with Palonosetron.
Ixazomib
Palonosetron may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Ketoprofen
Ketoprofen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ketorolac
Ketorolac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Ketorolac
The metabolism of Netupitant can be decreased when combined with Ketorolac.
Lamivudine
Palonosetron may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Lanreotide
The metabolism of Netupitant can be decreased when combined with Lanreotide.
Lansoprazole
The metabolism of Palonosetron can be decreased when combined with Lansoprazole.
Ledipasvir
Palonosetron may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
Lenalidomide
Palonosetron may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Leuprolide
Leuprolide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Levocarnitine
Palonosetron may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
Levofloxacin
Palonosetron may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Levosalbutamol
Palonosetron may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
Liothyronine
Liothyronine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Lisinopril
Palonosetron may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Lithium citrate
Lithium citrate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Lixisenatide
Palonosetron may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Lofexidine
The metabolism of Netupitant can be decreased when combined with Lofexidine.
Loperamide
The excretion of Loperamide can be decreased when combined with Netupitant.
Lubiprostone
Palonosetron may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Macitentan
Palonosetron may decrease the excretion rate of Macitentan which could result in a higher serum level.
Magnesium carbonate
Palonosetron may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
Magnesium chloride
Palonosetron may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
Magnesium hydroxide
Palonosetron may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium salicylate
Magnesium salicylate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Magnesium trisilicate
Palonosetron may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
Mannitol
Mannitol may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Maprotiline
The metabolism of Netupitant can be decreased when combined with Maprotiline.
Mecamylamine
Palonosetron may decrease the excretion rate of Mecamylamine which could result in a higher serum level.
Meclizine
The metabolism of Netupitant can be decreased when combined with Meclizine.
Meclofenamic acid
Meclofenamic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Medroxyprogesterone acetate
Palonosetron may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
Mefenamic acid
Mefenamic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Mefenamic acid
The metabolism of Netupitant can be decreased when combined with Mefenamic acid.
Megestrol acetate
Megestrol acetate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Meloxicam
Meloxicam may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Memantine
Palonosetron may decrease the excretion rate of Memantine which could result in a higher serum level.
Meropenem
Palonosetron may decrease the excretion rate of Meropenem which could result in a higher serum level.
Mesalazine
Mesalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Metamfetamine
The metabolism of Netupitant can be decreased when combined with Metamfetamine.
Metformin
Metformin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Methazolamide
Methazolamide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Methotrexate
Methotrexate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Methoxsalen
Palonosetron may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
Methyldopa
Palonosetron may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Methylnaltrexone
Palonosetron may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Methyltestosterone
Palonosetron may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
Metolazone
Palonosetron may decrease the excretion rate of Metolazone which could result in a higher serum level.
Metreleptin
The metabolism of Palonosetron can be increased when combined with Metreleptin.
Metreleptin
The metabolism of Netupitant can be increased when combined with Metreleptin.
Metyrapone
Palonosetron may decrease the excretion rate of Metyrapone which could result in a higher serum level.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Palonosetron.
Migalastat
Palonosetron may decrease the excretion rate of Migalastat which could result in a higher serum level.
Milrinone
Milrinone may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.
Mirtazapine
Palonosetron may increase the serotonergic activities of Mirtazapine.
Mycophenolate mofetil
Palonosetron may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
Mycophenolic acid
Palonosetron may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
N-acetyltyrosine
Palonosetron may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
Nabumetone
Nabumetone may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Nabumetone
The metabolism of Netupitant can be decreased when combined with Nabumetone.
Nadolol
Palonosetron may decrease the excretion rate of Nadolol which could result in a higher serum level.
Nadolol
The metabolism of Netupitant can be decreased when combined with Nadolol.
Naldemedine
Palonosetron may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Nalmefene
Palonosetron may decrease the excretion rate of Nalmefene which could result in a higher serum level.
Naloxone
Palonosetron may decrease the excretion rate of Naloxone which could result in a higher serum level.
Naproxen
Naproxen may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Naproxen
The metabolism of Netupitant can be decreased when combined with Naproxen.
Nateglinide
Palonosetron may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Nebivolol
The metabolism of Nebivolol can be decreased when combined with Palonosetron.
Nedocromil
Palonosetron may decrease the excretion rate of Nedocromil which could result in a higher serum level.
Nevirapine
The metabolism of Palonosetron can be decreased when combined with Nevirapine.
Nifedipine
Palonosetron may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Nilutamide
Palonosetron may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Nirogacestat
The metabolism of Nirogacestat can be decreased when combined with Palonosetron.
Nisoldipine
Palonosetron may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Nitric Oxide
Palonosetron may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
Nitrofurantoin
Palonosetron may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Nitroprusside
Nitroprusside may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Octinoxate
Palonosetron may decrease the excretion rate of Octinoxate which could result in a higher serum level.
Olanzapine
The metabolism of Netupitant can be decreased when combined with Olanzapine.
Olodaterol
The metabolism of Olodaterol can be decreased when combined with Netupitant.
Olsalazine
Olsalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Omaveloxolone
The serum concentration of Palonosetron can be decreased when it is combined with Omaveloxolone.
Oritavancin
The metabolism of Palonosetron can be decreased when combined with Oritavancin.
Oseltamivir
Oseltamivir may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Osilodrostat
The metabolism of Palonosetron can be decreased when combined with Osilodrostat.
Ospemifene
The metabolism of Palonosetron can be decreased when combined with Ospemifene.
Oxacillin
Palonosetron may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Oxaprozin
Oxaprozin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Oxybenzone
Palonosetron may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
Oxyquinoline
Palonosetron may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
Pamidronic acid
Pamidronic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Pantoprazole
Pantoprazole may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Parecoxib
Parecoxib may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Paromomycin
Paromomycin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Pasireotide
The metabolism of Netupitant can be decreased when combined with Pasireotide.
Pazopanib
The metabolism of Palonosetron can be decreased when combined with Pazopanib.
Peginterferon alfa-2b
The metabolism of Palonosetron can be decreased when combined with Peginterferon alfa-2b.
Peginterferon alfa-2b
The metabolism of Netupitant can be decreased when combined with Peginterferon alfa-2b.
Pentamidine
Pentamidine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Pentamidine
The metabolism of Netupitant can be decreased when combined with Pentamidine.
Pentetic acid
Palonosetron may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
Pentoxifylline
Palonosetron may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Perindopril
Palonosetron may decrease the excretion rate of Perindopril which could result in a higher serum level.
Permethrin
Palonosetron may decrease the excretion rate of Permethrin which could result in a higher serum level.
Phenazopyridine
Phenazopyridine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Phosphoric acid
Palonosetron may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
Phylloquinone
Palonosetron may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Picosulfuric acid
Palonosetron may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
Pindolol
The metabolism of Netupitant can be decreased when combined with Pindolol.
Piperacillin
Piperacillin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Pirfenidone
The metabolism of Pirfenidone can be decreased when combined with Palonosetron.
Pirfenidone
The metabolism of Netupitant can be decreased when combined with Pirfenidone.
Piroxicam
Piroxicam may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Piroxicam
The metabolism of Netupitant can be decreased when combined with Piroxicam.
Plerixafor
Palonosetron may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Polythiazide
Polythiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Potassium
Potassium may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Potassium acetate
Palonosetron may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
Potassium bicarbonate
Palonosetron may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
Potassium cation
Palonosetron may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Potassium chloride
Palonosetron may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
Potassium citrate
Potassium citrate may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Potassium nitrate
Palonosetron may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
Potassium sulfate
Palonosetron may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
Pralatrexate
Palonosetron may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Pralidoxime
Palonosetron may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
Prasugrel
Palonosetron may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Prasugrel
The metabolism of Netupitant can be decreased when combined with Prasugrel.
Prednisone
Palonosetron may decrease the excretion rate of Prednisone which could result in a higher serum level.
Probenecid
Palonosetron may decrease the excretion rate of Probenecid which could result in a higher serum level.
Procaine benzylpenicillin
Palonosetron may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Progesterone
The metabolism of Progesterone can be decreased when combined with Palonosetron.
Proguanil
The metabolism of Palonosetron can be decreased when combined with Proguanil.
Proguanil
The metabolism of Netupitant can be decreased when combined with Proguanil.
Propantheline
Palonosetron may decrease the excretion rate of Propantheline which could result in a higher serum level.
Propofol
The metabolism of Netupitant can be decreased when combined with Propofol.
Propranolol
Palonosetron may decrease the excretion rate of Propranolol which could result in a higher serum level.
Propyphenazone
Propyphenazone may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Prucalopride
Palonosetron may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Pyrazinamide
Pyrazinamide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Pyridoxine
Pyridoxine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Quinupristin
The metabolism of Netupitant can be decreased when combined with Quinupristin.
Rabeprazole
Palonosetron may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
Resorcinol
Palonosetron may decrease the excretion rate of Resorcinol which could result in a higher serum level.
Revefenacin
The metabolism of Revefenacin can be decreased when combined with Palonosetron.
Ribavirin
Palonosetron may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Rilzabrutinib
The metabolism of Palonosetron can be decreased when combined with Rilzabrutinib.
Rivaroxaban
Palonosetron may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Roflumilast
Palonosetron may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Rosiglitazone
Palonosetron may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Ruxolitinib
Palonosetron may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Sacubitril
Palonosetron may decrease the excretion rate of Sacubitril which could result in a higher serum level.
Salicylamide
Salicylamide may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Salicylic acid
Salicylic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Salicylic acid
The metabolism of Netupitant can be decreased when combined with Salicylic acid.
Salmon calcitonin
Salmon calcitonin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Salsalate
Salsalate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin
Palonosetron may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Seladelpar
The metabolism of Seladelpar can be decreased when combined with Netupitant.
Selenious acid
Palonosetron may decrease the excretion rate of Selenious acid which could result in a higher serum level.
Selenium
Palonosetron may decrease the excretion rate of Selenium which could result in a higher serum level.
Sildenafil
The metabolism of Palonosetron can be decreased when combined with Sildenafil.
Simvastatin
The metabolism of Simvastatin can be decreased when combined with Palonosetron.
Sitagliptin
Palonosetron may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Sodium acetate
Palonosetron may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
Sodium fluoride
Palonosetron may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
Sodium sulfate
Palonosetron may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
Sofosbuvir
Palonosetron may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Palonosetron.
Somatrogon
The metabolism of Palonosetron can be increased when combined with Somatrogon.
Somatrogon
The metabolism of Netupitant can be increased when combined with Somatrogon.
Sorafenib
Palonosetron may decrease the excretion rate of Sorafenib which could result in a higher serum level.
Sorbitol
Palonosetron may decrease the excretion rate of Sorbitol which could result in a higher serum level.
Spironolactone
Spironolactone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Sucralfate
Sucralfate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Sulbactam
Palonosetron may decrease the excretion rate of Sulbactam which could result in a higher serum level.
Sulfadiazine
Sulfadiazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Sulfamethoxazole
Palonosetron may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.
Sulfasalazine
Sulfasalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Sulindac
Sulindac may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Synthetic Conjugated Estrogens, A
Palonosetron may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.
Synthetic Conjugated Estrogens, B
Palonosetron may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.
Tacrolimus
Tacrolimus may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Tadalafil
Palonosetron may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Tafenoquine
The metabolism of Tafenoquine can be decreased when combined with Palonosetron.
Tafenoquine
The metabolism of Netupitant can be decreased when combined with Tafenoquine.
Talazoparib
The serum concentration of Talazoparib can be increased when it is combined with Netupitant.
Tamsulosin
Palonosetron may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Technetium Tc-99m exametazime
Palonosetron may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
Technetium Tc-99m pyrophosphate
Palonosetron may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
Teduglutide
Palonosetron may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Telavancin
Palonosetron may decrease the excretion rate of Telavancin which could result in a higher serum level.
Temozolomide
Palonosetron may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Temsirolimus
The metabolism of Palonosetron can be decreased when combined with Temsirolimus.
Tenofovir disoproxil
Tenofovir disoproxil may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Terbutaline
Palonosetron may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Testosterone
Palonosetron may decrease the excretion rate of Testosterone which could result in a higher serum level.
Testosterone cypionate
Palonosetron may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
Testosterone enanthate
Palonosetron may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
Testosterone propionate
Palonosetron may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
Testosterone undecanoate
Palonosetron may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Tetrabenazine
The metabolism of Tetrabenazine can be decreased when combined with Palonosetron.
Tetrabenazine
The metabolism of Netupitant can be decreased when combined with Tetrabenazine.
Tetracycline
Palonosetron may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Tetradecyl hydrogen sulfate (ester)
Palonosetron may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
Timolol
Timolol may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Timolol
The metabolism of Netupitant can be decreased when combined with Timolol.
Tinidazole
Palonosetron may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Tiopronin
Palonosetron may decrease the excretion rate of Tiopronin which could result in a higher serum level.
Tiotropium
Palonosetron may decrease the excretion rate of Tiotropium which could result in a higher serum level.
Tirofiban
Palonosetron may decrease the excretion rate of Tirofiban which could result in a higher serum level.
Tixocortol
Palonosetron may decrease the excretion rate of Tixocortol which could result in a higher serum level.
Tocopherol
Palonosetron may decrease the excretion rate of Tocopherol which could result in a higher serum level.
Tolazamide
Palonosetron may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Tolazamide
The metabolism of Netupitant can be decreased when combined with Tolazamide.
Tolmetin
Tolmetin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Tolterodine
Palonosetron may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Tolvaptan
Tolvaptan may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Topotecan
Palonosetron may decrease the excretion rate of Topotecan which could result in a higher serum level.
Torasemide
Torasemide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib
Palonosetron may decrease the excretion rate of Trametinib which could result in a higher serum level.
Treprostinil
The metabolism of Netupitant can be decreased when combined with Treprostinil.
Triamterene
Triamterene may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Triethylenetetramine
Palonosetron may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
Trifluridine
Palonosetron may decrease the excretion rate of Trifluridine which could result in a higher serum level.
Trimethoprim
Palonosetron may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Trimetrexate
Palonosetron may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
Trofinetide
The metabolism of Netupitant can be decreased when combined with Trofinetide.
Trolamine salicylate
Trolamine salicylate may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Trospium
The metabolism of Palonosetron can be decreased when combined with Trospium.
Trospium
The metabolism of Netupitant can be decreased when combined with Trospium.
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Palonosetron.
Vaborbactam
Palonosetron may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
Vadadustat
The serum concentration of Palonosetron can be increased when it is combined with Vadadustat.
Vadadustat
The serum concentration of Netupitant can be increased when it is combined with Vadadustat.
Valaciclovir
Valaciclovir may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Valbenazine
Palonosetron may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Valdecoxib
Valdecoxib may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Valganciclovir
Palonosetron may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Varenicline
Palonosetron may decrease the excretion rate of Varenicline which could result in a higher serum level.
Vemurafenib
The metabolism of Palonosetron can be decreased when combined with Vemurafenib.
Venlafaxine
The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Venlafaxine.
Vilanterol
Palonosetron may decrease the excretion rate of Vilanterol which could result in a higher serum level.
Viloxazine
The metabolism of Palonosetron can be decreased when combined with Viloxazine.
Viloxazine
The metabolism of Netupitant can be decreased when combined with Viloxazine.
Vinblastine
The metabolism of Palonosetron can be decreased when combined with Vinblastine.
Vinorelbine
The metabolism of Palonosetron can be decreased when combined with Vinorelbine.
Xanomeline
The metabolism of Xanomeline can be decreased when combined with Palonosetron.
Xanomeline
The metabolism of Xanomeline can be decreased when combined with Netupitant.
Zanamivir
Palonosetron may decrease the excretion rate of Zanamivir which could result in a higher serum level.